Spondylopathies

M13_SPONDYLOPATHY

ankylosing spondylitis: An autoimmune chronic inflammatory disorder characterized by inflammation in the vertebral joints of the spine and sacroiliac joints. It predominantly affects young males. Patients present with stiffness and pain in the spine.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M45-M49 Cause of death: ICD-10 — M45-M49 2 out of 7 registries used, show all original rules.	51349
4. Check minimum number of events None	51349
5. Include endpoints M13_ANKYLOSPON M13_SPINENTHES M13_SACROILIITIS M13_OSTEOMYELVERTEB M13_DISCINFECTION M13_DISCITIS M13_SPONDYLOINFECTION M13_SPONDYLINFLAMNAS M13_SPONDYLOSIS M13_SPINSTENOSIS M13_FORESTIER M13_KISSING M13_SPONDYLOTRAUM M13_FATIGFRACT M13_VERTEBCOLLAPSE M13_SPONDYLOPATHYNAS M13_SPONDYLOPATHINOTH	53933
6. Filter based on genotype QC (FinnGen only)	53933

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	M13_SPONDYLOPATHY
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_ANKYLOSPON\|M13_SPINENTHES\|M13_SACROILIITIS\|M13_OSTEOMYELVERTEB\|M13_DISCINFECTION\|M13_DISCITIS\|M13_SPONDYLOINFECTION\|M13_SPONDYLINFLAMNAS\|M13_SPONDYLOSIS\|M13_SPINSTENOSIS\|M13_FORESTIER\|M13_KISSING\|M13_SPONDYLOTRAUM\|M13_FATIGFRACT\|M13_VERTEBCOLLAPSE\|M13_SPONDYLOPATHYNAS\|M13_SPONDYLOPATHINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M4[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M4[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spondylopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	367998	193655	171564
Only index persons	317161	172034	145127
Unadjusted period prevalence (%)
Whole population	5.18	5.55	4.79
Only index persons	5.97	6.32	5.54
Median age at first event (years)
Whole population	59.70	61.03	58.17
Only index persons	58.75	60.04	57.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	53933	29113	24820
Unadjusted period prevalence (%)	10.39	9.92	10.94
Median age at first event (years)	58.73	58.10	59.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21000: Matched controls
154552

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M02AA07

ATC

piroxicam; topical

2.0

323.0

6547

28988

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

11.3

323.0

1538

1073

M54.2

ICD-10 Finland

Cervicalgia

8.5

323.0

2214

2114

I10

ICD-10 Finland

Essential (primary) hypertension

1.9

323.0

8627

41904

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

323.0

663

M01AE02

ATC

naproxen; oral, rectal

2.1

323.0

11945

59120

A07EC01

ATC

sulfasalazine; oral, rectal

8.0

323.0

3700

4022

M01AC06

ATC

meloxicam; systemic, rectal

2.8

323.0

8296

29395

N03AX16

ATC

pregabalin; oral

9.0

323.0

8130

10150

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.4

323.0

5537

14612

M43.1

ICD-10 Finland

Spondylolisthesis

61.2

323.0

1584

206

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

323.0

4047

14459

R51.80

ICD-10 Finland

Headache

2.7

323.0

3041

9058

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.9

323.0

1912

2209

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2626.8

323.0

1042

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

17.7

323.0

573

244

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.5

323.0

3301

7747

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

25.0

323.0

756

230

UJF32

NOMESCO Finland

Coloscopy

2.4

323.0

4363

15182

M01AH05

ATC

etoricoxib; oral

3.2

323.0

14242

61088

J01AA02

ATC

doxycycline; systemic

2.0

323.0

15824

92891

A02BC02

ATC

pantoprazole; systemic

2.8

323.0

13547

61448

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

24.3

323.0

2695

930

M03BX02

ATC

tizanidine; oral

3.1

323.0

14757

67142

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

63.5

323.0

489

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

323.0

7635

34962

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

323.0

406

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

323.0

3012

7840

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.0

323.0

5171

14952

L03

ICPC

Low back symptom/complaint

4.5

323.0

5823

12118

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

323.0

6479

24400

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

323.0

4617

18010

M47.82

ICD-10 Finland

Other spondylosis, cervical region

79.3

323.0

2500

263

R52.2

ICD-10 Finland

Other chronic pain

7.8

323.0

874

858

M45

ICD-10 Finland

Ankylosing spondylitis

351.7

323.0

2537

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

323.0

572

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

21.8

323.0

3648

1476

L04AB01

ATC

etanercept; parenteral

10.6

323.0

714

511

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3060.1

323.0

2280

M03BC01

ATC

orphenadrine (citrate); systemic

3.3

323.0

6490

18403

A02BC03

ATC

lansoprazole; oral

2.5

323.0

5970

21218

A02BC05

ATC

esomeprazole; systemic

2.3

323.0

8159

33763

N02BE01

ATC

paracetamol; systemic, rectal

3.4

323.0

17815

95885

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

1293.3

323.0

1287

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

11.2

323.0

1599

1124

M54.4

ICD-10 Finland

Lumbago with sciatica

11.9

323.0

5960

4977

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

323.0

637

SPAT1153

SPAT

Removal of sutures

2.5

323.0

5402

18987

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.6

323.0

1822

3149

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.1

323.0

2109

3287

M01AH02

ATC

rofecoxib; oral

3.3

323.0

2444

5901

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

17.9

323.0

745

317

M01AX17

ATC

nimesulide; oral

2.6

323.0

4688

15611

N06AX21

ATC

duloxetine; oral

5.9

323.0

3540

5128

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

10287

52693

N06AX16

ATC

venlafaxine; oral

2.6

323.0

3327

10288

9211

FHL

Exploration or removal of diskusprolapse

358.6

323.0

384

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

6.0

323.0

4107

5991

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

56.0

323.0

1041

144

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

323.0

7563

29933

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

65.2

323.0

1037

123

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1492.2

323.0

1278

M50.3

ICD-10 Finland

Other cervical disc degeneration

49.2

323.0

880

137

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

9.5

323.0

3368

3050

M01AH01

ATC

celecoxib; oral (coxibs)

3.7

323.0

4270

9877

N06AX11

ATC

mirtazapine; oral

2.1

323.0

6318

26295

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

323.0

7737

32683

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

22.0

323.0

1568

564

N02AX02

ATC

tramadol; systemic, rectal

5.2

323.0

11655

30085

N06AA09

ATC

amitriptyline; systemic

5.2

323.0

2401

3721

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.2

323.0

11154

40440

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

265.8

323.0

1551

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

715.5

323.0

660

M54.5

ICD-10 Finland

Low back pain

5.9

323.0

9236

18273

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.9

323.0

829

708

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

323.0

6915

29255

M54.3

ICD-10 Finland

Sciatica

15.0

323.0

1684

892

L04AB04

ATC

adalimumab; parenteral

8.4

323.0

928

849

M54

ICD-10 Finland

Dorsalgia

3.0

323.0

2442

6411

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

323.0

2007

4964

A02BC01

ATC

omeprazole; systemic

2.2

323.0

5065

19666

C07AB07

ATC

bisoprolol; oral

1.9

323.0

7242

33204

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.8

323.0

3217

9380

M70.6

ICD-10 Finland

Trochanteric bursitis

4.0

323.0

2015

3979

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

552.0

323.0

1002

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.0

323.0

3165

2987

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

66.7

323.0

2591

326

M43.0

ICD-10 Finland

Spondylolysis

87.7

323.0

681

M25.5

ICD-10 Finland

Pain in joint

2.6

323.0

6338

21717

M01AB05

ATC

diclofenac; systemic, rectal

2.6

323.0

14790

73993

M79.6

ICD-10 Finland

Pain in limb

2.7

323.0

7305

25445

H02AB06

ATC

prednisolone; systemic

2.5

323.0

9980

41558

M48.0

ICD-10 Finland

Spinal stenosis

282.7

323.0

7451

300

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

71.9

323.0

6265

908

L86

ICPC

Back syndrome with radiating pain

11.1

323.0

1615

1146

L28

ICPC

Limited function/disability (L)

3.2

323.0

2406

5922

M54.6

ICD-10 Finland

Pain in thoracic spine

5.5

323.0

1678

2422

R06.0

ICD-10 Finland

Dyspnoea

2.3

323.0

3976

14320

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

131.9

323.0

942

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

24.5

323.0

526

162

71310

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis cervicalis

+∞

323.0

364

L88

ICPC

Rheumatoid/seropositive arthritis

6.3

323.0

1043

1267

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

5.1

323.0

1232

1850

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

50.4

323.0

3428

596

N02AJ06

ATC

codeine and paracetamol; systemic

3.0

323.0

8911

30362

J01DB01

ATC

cefalexin; oral

2.0

323.0

16199

97850

S18

ICPC

Laceration/cut

2.3

323.0

7262

29092

M47.9

ICD-10 Finland

Spondylosis, unspecified

175.5

323.0

2085

N03AX12

ATC

gabapentin; oral

11.6

323.0

5852

5000

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

53.7

323.0

1739

259

G54.0

ICD-10 Finland

Brachial plexus disorders

8.7

323.0

905

793

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

323.0

18516

118997

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.7

323.0

1924

4072

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

323.0

4558

15977

M54.1

ICD-10 Finland

Radiculopathy

24.7

323.0

1451

463

R4110

NOMESCO Finland

Physiotherapy

2.3

323.0

5079

19059

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

21.1

323.0

853

309

L01

ICPC

Neck symptom/complaint

3.5

323.0

2942

6818

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

61.1

323.0

4803

746

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

323.0

5508

19660

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

389.8

323.0

5704

146

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

323.0

5229

18392

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

285.2

323.0

1487

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

352.0

323.0

2687

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

72.7

323.0

1750

193

M53.1

ICD-10 Finland

Cervicobrachial syndrome

5.3

323.0

3277

5226

N02AA05

ATC

oxycodone; systemic

3.7

323.0

2708

5948

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

4.3

323.0

2747

5251

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

81.9

322.0

404

G44.2

ICD-10 Finland

Tension-type headache

2.7

320.6

2618

7801

M79.7

ICD-10 Finland

Fibromyalgia

6.8

318.4

895

1000

ACC51

NOMESCO Finland

Release of median nerve

3.4

313.9

1733

3952

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

310.4

2909

9360

WX110

NOMESCO Finland

Local anesthesy

1.8

307.1

13395

77403

R42

ICD-10 Finland

Dizziness and giddiness

2.3

306.8

3343

11623

L08

ICPC

Shoulder symptom/complaint

2.4

306.8

3142

10590

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.4

306.6

1039

1481

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

301.6

1726

4041

N05CF01

ATC

zopiclone; oral

1.9

301.0

5808

25714

XA402

NOMESCO Finland

ENMG

7.8

298.9

771

756

ZXA00

NOMESCO Finland

Right side

2.1

298.4

4484

18002

AA1AD

NOMESCO Finland

CT of head and brain

2.2

297.0

3547

12872

L02

ICPC

Back symptom/complaint

3.3

294.3

1740

4171

A01

ICPC

Pain general/multiple sites

3.8

286.6

1370

2767

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.6

285.2

1454

3102

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

284.3

6561

30796

NF1AA

NOMESCO Finland

Hip X-ray examination

4.1

284.2

1272

2421

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

267.5

283.1

324

SPAT1301

SPAT

No procedures

2.0

282.9

4823

20299

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

281.0

3134

10979

G47.3

ICD-10 Finland

Sleep apnoea

2.0

280.3

4297

17331

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

278.2

4863

20641

71312

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis

+∞

276.5

299

M01AX05

ATC

glucosamine; oral

2.7

275.6

2240

6616

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.4

274.1

1549

3583

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.6

274.1

1398

2980

L17

ICPC

Foot/toe symptom/complaint

2.1

272.2

3761

14502

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.8

271.4

1022

1637

L13

ICPC

Hip symptom/complaint

2.8

270.3

2004

5595

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.0

269.7

1839

4861

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

41.7

268.6

373

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

72.7

267.1

340

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

266.1

10790

59761

M79.1

ICD-10 Finland

Myalgia

2.5

264.5

2378

7432

J01DA01

ATC

[U] cefalexin; systemic

1.7

255.5

12560

73027

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

253.7

1457

3405

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.0

253.6

1669

4301

ZXA05

NOMESCO Finland

Left side

2.0

253.5

4099

16794

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

253.1

3793

15074

J01FF01

ATC

clindamycin; systemic

1.9

252.9

5105

22701

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

251.5

9516

51364

M53.2

ICD-10 Finland

Spinal instabilities

92.9

251.4

311

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

7.6

250.3

654

653

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

9.0

249.4

588

495

SPAT1263

SPAT

Sampling

1.7

247.6

6894

33991

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

247.2

3149

11668

M13.9

ICD-10 Finland

Arthritis, unspecified

3.1

246.7

1533

3792

A02BA02

ATC

ranitidine; systemic

2.1

244.7

3391

13024

M01AB55

ATC

diclofenac, combinations; oral

3.7

243.2

1196

2466

M54.8

ICD-10 Finland

Other dorsalgia

5.6

243.0

797

1088

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

9.0

242.8

570

476

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

242.8

13709

82183

Z50.1

ICD-10 Finland

Other physical therapy

4.2

242.4

1051

1936

P01BA02

ATC

hydroxychloroquine; oral

3.0

242.3

1608

4162

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

995.5

241.5

266

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

241.5

2773

9788

M01AB08

ATC

etodolac; oral

3.1

240.6

1533

3857

J01MA02

ATC

ciprofloxacin; systemic

1.7

238.3

6698

33023

SPAT1216

SPAT

Assessment of functional ability

2.6

236.1

1933

5706

P01AB01

ATC

metronidazole; oral, rectal

1.7

235.9

7305

37031

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

235.2

1725

4763

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.6

233.4

1195

2547

L04AB06

ATC

golimumab; parenteral

12.5

231.1

460

276

J01FA06

ATC

roxithromycin; oral

1.7

230.1

7636

39402

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

104.8

230.0

281

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

228.7

4818

21612

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

629.9

228.5

254

SPAT1310

SPAT

Counselling related to known health issue

1.8

227.1

4805

21576

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

226.5

245

G04CA02

ATC

tamsulosin; oral

2.0

226.3

3402

13467

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

225.5

244

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.8

225.4

634

706

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

225.4

6081

29497

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

48.2

224.9

304

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

221.9

2961

11147

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

221.2

9980

55725

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

609.8

221.1

246

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

66.2

220.5

284

C10AA01

ATC

simvastatin; oral

1.8

219.8

5186

24093

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

26.0

218.2

337

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

451.3

216.6

243

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

216.6

4049

17375

B01AB05

ATC

enoxaparin; parenteral

1.8

215.7

4455

19789

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

214.5

3427

13867

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

212.9

5403

25633

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.0

212.2

969

1868

M01AX01

ATC

nabumetone; oral

4.4

211.4

864

1500

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

862.5

210.1

232

N05BA01

ATC

diazepam; systemic, rectal

2.2

209.6

2442

8634

L15

ICPC

Knee symptom/complaint

2.1

208.9

2908

11119

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

152.6

207.9

246

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.0

207.6

923

1736

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

207.6

2892

11059

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

207.1

3386

13802

C03CA01

ATC

furosemide; systemic

1.9

206.7

3839

16399

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

205.3

1331

3377

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

203.7

11259

65565

WZA90

NOMESCO Finland

Other doctors statement

1.9

203.2

3999

17418

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

203.1

6108

30377

R52.9

ICD-10 Finland

Pain, unspecified

2.9

201.1

1422

3821

N05BA04

ATC

oxazepam; oral

1.8

199.8

4353

19605

C10AA05

ATC

atorvastatin; oral

1.7

199.6

4888

22850

C08CA01

ATC

amlodipine; oral

1.8

198.8

4705

21755

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

197.3

2434

8817

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.0

196.5

880

1665

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

196.1

3764

16230

SPAT1260

SPAT

Consultation of another employee

2.1

195.9

2561

9513

M48.9

ICD-10 Finland

Spondylopathy, unspecified

236.4

194.6

224

N06AA10

ATC

nortriptyline; systemic

6.4

193.4

564

660

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

55.9

193.3

255

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

4.3

193.2

812

1447

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.4

193.1

512

522

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.3

193.0

802

1414

K02.1

ICD-10 Finland

Caries of dentine

1.5

192.4

10945

63777

WX402

NOMESCO Finland

General anaesthesia

2.0

191.5

3112

12615

N03AE01

ATC

clonazepam; systemic

3.2

189.4

1130

2701

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.0

188.8

583

736

L84

ICPC

Back syndrome without radiat pain

4.2

188.4

795

1422

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

188.2

8128

44239

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

262.4

186.0

213

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

44.1

185.8

255

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

185.7

201

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.3

184.5

2011

6863

M01AH03

ATC

valdecoxib; oral

3.0

183.8

1203

3068

M02AA10

ATC

ketoprofen; topical

2.0

183.6

2662

10304

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

183.6

9549

54234

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

182.9

198

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

182.6

1462

4235

J01FA10

ATC

azithromycin; systemic

1.5

181.8

11145

65689

R5599

NOMESCO Finland

Other rehabilitation service

5.9

181.3

565

722

XKD00

NOMESCO Finland

Uroflowmetry

2.2

180.8

2108

7421

N05AH04

ATC

quetiapine; oral

1.9

180.8

3248

13635

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

180.7

12023

72159

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.7

180.6

1420

4066

M46.4

ICD-10 Finland

Discitis, unspecified

742.2

180.6

200

R52.1

ICD-10 Finland

Chronic intractable pain

19.3

180.0

303

117

SPAT1229

SPAT

Assessment of need for aid

3.2

178.9

1054

2494

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

178.5

2114

7495

J01CA04

ATC

amoxicillin; systemic

1.6

176.5

15456

98632

N02AJ13

ATC

tramadol and paracetamol; systemic

7.2

175.4

472

492

N06AB04

ATC

citalopram; systemic

1.8

174.8

3905

17624

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

174.6

189

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

174.1

1869

6324

A06AD11

ATC

lactulose; oral

2.1

174.0

2254

8309

M35.7

ICD-10 Finland

Hypermobility syndrome

8.9

173.0

408

343

M01AC01

ATC

piroxicam; systemic, rectal

2.1

172.3

2199

8054

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

172.1

1603

5046

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

171.8

186

N02AC04

ATC

dextropropoxyphene; oral

4.2

171.7

738

1342

J01FA09

ATC

clarithromycin; systemic

1.6

171.4

5930

30323

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

170.8

7638

41618

R01AD09

ATC

mometasone; nasal

1.5

170.0

8383

46725

L04AA13

ATC

leflunomide; oral

5.1

168.0

595

886

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

167.7

3271

14093

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

167.5

1712

5649

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

167.3

5749

29306

UKC02

NOMESCO Finland

Cystoscopy

2.1

167.1

2194

8125

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

166.5

1211

3303

R53

ICD-10 Finland

Malaise and fatigue

1.8

161.9

3287

14338

M01AB01

ATC

indometacin; systemic, rectal

2.7

161.5

1277

3662

H02AB04

ATC

methylprednisolone; systemic

2.0

161.5

2555

10195

N04BC05

ATC

pramipexole; oral

3.0

161.2

1060

2705

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

160.9

4957

24494

WX290

NOMESCO Finland

Other blockade of nerve

1.5

160.5

8887

50617

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.3

159.9

1652

5476

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

441.9

159.5

179

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

159.5

1396

4243

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

4.0

158.1

703

1319

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

157.7

2722

11210

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.6

157.5

1295

3799

D07AC01

ATC

betamethasone; topical

1.6

157.4

5743

29630

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

329.0

157.0

178

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.9

156.9

1079

2836

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

156.7

1737

5953

M77.1

ICD-10 Finland

Lateral epicondylitis

2.3

156.3

1676

5653

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

155.6

2501

10029

SPAT1312

SPAT

General health counselling

1.6

155.3

4643

22720

X58

ICD-10 Finland

Exposure to other specified factors

1.9

153.5

2551

10353

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

153.3

6760

36453

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

1278.5

152.1

167

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

626.1

152.0

169

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

151.5

164

H02AB07

ATC

prednisone; oral

1.9

151.1

2458

9893

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.8

150.1

554

863

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

9.8

149.6

334

254

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

35.6

147.6

211

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

147.1

3312

14884

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

159.5

145.9

172

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

145.7

1381

4374

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

599.9

145.6

162

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

89.1

145.1

180

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

21.0

144.8

237

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.6

144.7

465

617

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

144.7

1967

7368

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

144.3

5265

27041

7210A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis without myelopathy

+∞

144.1

156

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

142.9

987

2599

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.0

142.7

510

767

N05CF02

ATC

zolpidem; oral

1.8

142.6

3147

14043

R07.3

ICD-10 Finland

Other chest pain

2.4

141.9

1372

4388

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

141.8

1547

5251

C10AA07

ATC

rosuvastatin; oral

1.8

141.8

3049

13489

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

141.6

4319

21165

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.6

141.1

709

1479

R02

ICPC

Shortness of breath/dyspnoea

2.3

141.0

1534

5201

Z71.8

ICD-10 Finland

Other specified counselling

1.7

140.8

3900

18609

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

14.9

140.7

259

129

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.2

140.7

817

1907

SPAT1254

SPAT

Administration of medicine

2.0

140.2

1956

7398

L83

ICPC

Neck syndrome

15.1

139.7

256

126

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

139.4

1801

6596

7213A

ICD-9 Finland

Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy

+∞

139.4

151

ZZH40

NOMESCO Finland

Substitute of bone

11.0

138.3

291

197

L12

ICPC

Hand/finger symptom/complaint

2.0

138.0

2114

8296

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

137.9

2422

10001

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.7

137.7

436

568

WX002

NOMESCO Finland

Sedation and analgesia

1.8

137.2

2749

11875

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

136.0

3040

13597

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.6

135.8

440

590

L29

ICPC

Musculoskeletal sympt/complt other

2.7

134.9

1064

3038

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

61.9

134.8

175

EBA00

NOMESCO Finland

Extraction of tooth

1.5

134.7

5442

28553

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

25.0

134.4

209

M41.9

ICD-10 Finland

Scoliosis, unspecified

19.4

134.3

225

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

133.2

2567

10937

WX308

NOMESCO Finland

Sacral anesthesy

165.2

132.7

156

R06AE07

ATC

cetirizine; oral

1.5

132.7

7649

43356

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

131.8

1560

5492

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

131.3

2615

11257

M47.8

ICD-10 Finland

Other spondylosis

225.2

130.9

151

TAB20

NOMESCO Finland

Epidural puncture

13.4

130.6

251

139

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.6

130.5

648

1338

SPAT1097

SPAT

Recording of ECG

2.1

130.4

1718

6337

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

130.3

1988

7780

NA3BG

SPAT

4.3

129.6

534

931

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.1

127.8

317

291

R60.0

ICD-10 Finland

Localized oedema

2.2

127.2

1402

4773

M50.8

ICD-10 Finland

Other cervical disc disorders

96.4

126.9

156

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

126.8

1460

5072

R03DC03

ATC

montelukast; oral

1.8

126.6

2762

12233

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

126.4

2846

12732

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.9

126.2

297

249

XX2CT

NOMESCO Finland

Other injection with CT guidance

215.9

125.4

145

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.5

125.2

488

805

C07AA05

ATC

propranolol; systemic

1.7

124.5

3310

15546

Z01.2

ICD-10 Finland

Dental examination

1.5

123.4

7093

40002

A28

ICPC

Limited function/disability NOS

2.1

122.9

1502

5360

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

122.6

1625

6003

R01AD08

ATC

fluticasone; nasal

1.5

122.2

5126

27009

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

122.1

1522

5477

C07AB02

ATC

metoprolol; systemic

1.8

122.0

2704

12024

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.7

121.3

592

1204

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

21.7

121.2

196

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.0

120.0

786

1994

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

119.9

1035

3109

N03AX09

ATC

lamotrigine; oral

2.6

119.8

998

2939

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

119.1

6756

37927

M76.6

ICD-10 Finland

Achilles tendinitis

3.3

118.9

666

1512

R05FB02

ATC

cough suppressants and expectorants

1.5

118.9

6200

34208

M03BX01

ATC

baclofen; systemic

5.4

118.9

393

540

R4120

NOMESCO Finland

Occupational therapy

2.5

118.9

1068

3277

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

118.2

128

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

118.1

1709

6540

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

7.7

118.0

303

294

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

118.0

8170

47665

R03BB04

ATC

tiotropium bromide; inhalant

2.2

117.6

1413

4997

J02AC01

ATC

fluconazole; systemic

1.4

117.1

7008

39729

ZXA10

NOMESCO Finland

Bilateral

1.8

117.0

2487

10905

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

116.9

1153

3713

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

116.9

1666

6333

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

116.6

1629

6143

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

116.5

4574

23689

N06AB10

ATC

escitalopram; oral

1.6

116.5

3655

17914

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

116.4

3549

17266

M01AE52

ATC

naproxen and esomeprazole; oral

3.4

116.3

631

1398

T90

ICPC

Diabetes non-insulin dependent

1.7

116.0

2800

12760

C09CA01

ATC

losartan; oral

1.7

115.9

3160

14915

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

115.8

2222

9419

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

115.7

1870

7460

R05

ICPC

Cough

1.7

115.7

3026

14115

L16

ICPC

Ankle symptom/complaint

2.1

115.4

1422

5086

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.6

115.1

947

2768

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

31.9

114.9

168

WX704

NOMESCO Finland

Intubation

2.3

114.5

1190

3934

J01MA12

ATC

levofloxacin; systemic

1.7

114.4

2752

12527

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

11.0

114.3

240

162

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

113.9

1031

3176

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

113.8

3485

16960

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

195.9

113.6

132

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

113.1

1286

4436

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

112.6

1459

5330

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

917.3

112.4

124

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

112.1

1368

4870

K30

ICD-10 Finland

Functional dyspepsia

2.0

111.9

1527

5701

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

111.8

2649

11995

B01AC04

ATC

clopidogrel; oral

2.0

110.8

1603

6124

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

110.3

1041

3276

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

110.0

1272

4421

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

109.7

865

2465

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

109.6

1582

6039

R1250

NOMESCO Finland

Evaluation of functional capability

4.2

109.3

456

805

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.9

109.1

749

1959

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

109.0

1089

3529

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

108.9

2111

8965

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

108.9

1237

4263

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

108.8

1918

7888

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

887.5

108.8

120

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.5

108.7

427

710

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

108.4

1829

7403

L04AC10

ATC

secukinumab; parenteral

12.2

108.2

216

131

R05

ICD-10 Finland

Cough

1.7

108.2

2587

11739

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

107.2

803

2220

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

107.2

3223

15585

M46.0

ICD-10 Finland

Spinal enthesopathy

119.4

107.1

129

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

46.7

107.1

145

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

106.9

4182

21570

Z01.9

ICD-10 Finland

Special examination, unspecified

2.7

106.7

825

2324

R03AC03

ATC

terbutaline; inhalant

1.8

106.5

2327

10267

WZA10

NOMESCO Finland

Long statement of health and health related matters

5.0

106.0

376

561

C01DA14

ATC

isosorbide mononitrate; oral

1.9

105.9

1782

7204

Z00.0

ICD-10 Finland

General medical examination

1.7

105.8

2577

11748

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

105.7

1694

6727

S06.0

ICD-10 Finland

Concussion

2.0

105.6

1592

6176

L04AB05

ATC

certolizumab pegol; parenteral

13.4

105.2

202

112

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

105.2

3427

16904

E0000UV

ATC

1.4

105.1

6380

36068

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

104.9

3405

16780

R03BA01

ATC

beclometasone; inhalant

1.7

104.5

2290

10111

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

104.2

943

2901

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

103.7

1282

4585

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.7

103.0

787

2200

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

102.8

1763

7172

C08CA13

ATC

lercanidipine; oral

2.0

102.7

1471

5592

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.5

102.5

531

1134

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

102.1

1029

3345

K07.60

ICD-10 Finland

Snapping jaw

2.5

101.9

894

2704

A10BA02

ATC

metformin; oral

1.6

101.8

3639

18347

WZC30

NOMESCO Finland

Teaching

1.8

101.5

1897

7949

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.8

101.2

715

1904

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

101.0

949

2979

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

100.8

3080

14928

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

100.6

109

R01AD12

ATC

fluticasone furoate; nasal

1.5

100.5

5395

29718

G04CA01

ATC

alfuzosin; oral

1.9

100.3

1589

6277

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

99.7

1414

5353

H20.1

ICD-10 Finland

Chronic iridocyclitis

6.3

99.6

294

350

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

6.0

99.3

303

377

SPAT1262

SPAT

Handing over of treatment supplies

1.7

99.3

2346

10585

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.7

98.6

747

2077

SPAT1058

SPAT

PEF monitoring instruction

2.4

98.4

969

3115

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

98.2

1898

8039

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

98.2

1497

5827

C10AX09

ATC

ezetimibe; oral

2.1

97.9

1242

4488

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

97.7

1109

3816

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

97.1

865

2639

N07BA03

ATC

varenicline; oral

2.2

97.0

1113

3848

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

96.4

1063

3609

R03BA05

ATC

fluticasone; inhalant

1.6

96.1

2901

13997

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

96.0

4902

26680

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.8

95.6

452

895

A03FA02

ATC

cisapride; oral, rectal

2.2

95.4

1074

3678

J20

ICD-10 Finland

Acute bronchitis

2.0

95.3

1366

5189

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

95.2

850

2596

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

95.1

891

2792

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

95.0

2402

11043

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

57.4

94.7

124

M75.8

ICD-10 Finland

Other shoulder lesions

3.1

93.9

586

1438

R13

ICD-10 Finland

Dysphagia

2.5

93.8

843

2581

R35

ICD-10 Finland

Polyuria

2.5

93.6

807

2418

C09CA06

ATC

candesartan; oral

1.6

93.4

3215

16021

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

93.3

1910

8235

M19.8

ICD-10 Finland

Other specified arthrosis

3.4

93.0

492

1069

RF210

NOMESCO Finland

3.4

92.3

491

1071

R50.9

ICD-10 Finland

Fever, unspecified

1.7

92.2

2127

9514

M04AA01

ATC

allopurinol; systemic

1.9

91.7

1594

6504

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

91.7

2492

11682

RF420

NOMESCO Finland

5.7

91.5

290

379

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.5

91.2

477

1027

KMAK

NOMESCO Finland

1.4

91.0

9672

59793

NA1BG

SPAT

5.6

90.7

291

386

R96

ICPC

Asthma

2.2

90.6

1059

3689

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

90.5

G83.4

ICD-10 Finland

Cauda equina syndrome

35.4

90.4

129

SPAT1240

SPAT

Therapeutic discussion

1.8

90.4

1781

7578

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.7

90.2

435

876

D07AD01

ATC

clobetasol; topical

1.7

90.2

2327

10747

NF1DA

NOMESCO Finland

X-ray of hips

5.4

90.0

298

411

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

89.9

640

1712

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

89.8

2247

10289

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.5

89.7

470

1013

A02BA04

ATC

nizatidine; systemic

2.1

89.3

1150

4179

XF402

NOMESCO Finland

ECG with work load test

2.0

89.3

1266

4787

A46

ICD-10 Finland

Erysipelas

1.8

89.2

1902

8300

WX320

NOMESCO Finland

Spinalanesthesy

1.6

89.1

2970

14668

SFA00

NOMESCO Finland

Small filling

1.7

88.6

2122

9592

N05CD07

ATC

temazepam; oral

1.8

88.5

1805

7768

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

87.9

3738

19521

M48.8

ICD-10 Finland

Other specified spondylopathies

69.1

87.8

112

R03BA02

ATC

budesonide; inhalant

1.6

87.8

2776

13528

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.8

87.7

1861

8107

M76.0

ICD-10 Finland

Gluteal tendinitis

6.0

87.6

267

332

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

87.6

1338

5203

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.7

87.3

330

528

P06

ICPC

Sleep disturbance

1.9

87.3

1516

6181

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.7

87.2

668

1868

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

86.5

986

3393

S22.3

ICD-10 Finland

Fracture of rib

2.2

85.5

981

3386

P03

ICPC

Feeling depressed

1.9

85.0

1462

5935

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

11.5

85.0

174

112

A02BC04

ATC

rabeprazole; oral

1.9

84.7

1323

5188

N06AB03

ATC

fluoxetine; oral

1.7

84.6

1980

8879

SPAT1325

SPAT

Vaccination

1.5

84.6

3779

19926

NG1DA

NOMESCO Finland

X-ray of knees

4.9

84.2

304

463

205

Kela drug reimbursment

Chronic hypertension

1.5

84.1

3257

16644

M15

ICD-10 Finland

Polyarthrosis

3.2

83.6

491

1154

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

83.4

4424

24147

M01AB51

ATC

indometacin, combinations; oral, rectal

3.6

82.7

411

849

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

13.0

82.6

160

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

82.6

1315

5191

C09AA05

ATC

ramipril; oral

1.6

82.5

2890

14422

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.8

82.3

1715

7423

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

82.3

3215

16450

SPAT1211

SPAT

Application of soft bandage

2.1

82.2

1098

4048

-1

NOMESCO Finland

1.4

81.9

5730

32889

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

81.6

976

3433

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.1

81.2

284

418

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

81.1

4486

24658

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.6

81.0

405

841

ZX120

NOMESCO Finland

Intravenous

1.9

80.8

1351

5427

G04BD12

ATC

mirabegron; oral

2.2

80.6

905

3093

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.3

80.3

450

1022

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

7.4

80.2

210

211

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

80.0

12863

83932

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

80.0

987

3519

P76

ICPC

Depressive disorder

2.0

79.8

1072

3962

H02BX01

ATC

methylprednisolone, combinations; systemic

2.6

79.7

665

1955

AN1

Coronary angiography

2.0

79.3

1114

4190

R06.5

ICD-10 Finland

Mouth breathing

1.8

79.2

1465

6097

S29

ICPC

Skin symptom/complaint other

1.7

79.0

1922

8709

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

78.9

755

2389

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.9

78.5

542

1421

TAB00

NOMESCO Finland

Lumbar puncture

2.4

78.3

729

2274

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

78.1

3050

15582

N06AX12

ATC

bupropion; oral

1.9

78.0

1199

4671

H57.1

ICD-10 Finland

Ocular pain

2.8

77.9

539

1416

SPAT1202

SPAT

Intra-articular injection

3.7

77.9

371

740

SPAT1284

SPAT

Extensive health certificate

2.9

77.7

512

1303

N06AA12

ATC

doxepin; systemic

2.3

77.7

769

2475

ACC53

NOMESCO Finland

Release of ulnar nerve

4.4

77.7

313

535

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

77.7

4349

23931

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

77.6

1805

8069

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

77.6

843

2837

L11

ICPC

Wrist symptom/complaint

2.0

77.4

1085

4076

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

77.1

662

1978

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

77.1

942

3344

J01EA01

ATC

trimethoprim; systemic

1.5

77.1

3477

18326

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.2

76.9

440

1015

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.0

76.7

269

397

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.4

76.7

743

2365

B01AF01

ATC

rivaroxaban; oral

2.0

76.7

1069

4008

M50

ICD-10 Finland

Cervical disc disorders

9.3

76.6

174

138

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

76.2

1489

6305

SPAT1255

SPAT

Intravenous administration of medicine

2.2

75.9

890

3100

W19

ICD-10 Finland

Unspecified fall

1.9

75.8

1304

5287

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

75.7

949

3403

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

75.7

1144

4426

R06AX27

ATC

desloratadine; oral

1.4

75.6

4726

26517

M65.3

ICD-10 Finland

Trigger finger

2.4

75.1

683

2103

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

75.0

1211

4800

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.8

74.6

352

696

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

74.5

1009

3738

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

74.5

1046

3931

M89.0

ICD-10 Finland

Algoneurodystrophy

7.1

74.5

200

209

J45

ICD-10 Finland

Asthma

1.8

74.5

1390

5795

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.7

74.3

234

304

A29

ICPC

General symptom/complaint other

1.8

74.3

1321

5419

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

74.3

3049

15732

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

73.9

1000

3702

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.0

73.8

326

608

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

73.6

941

3404

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

73.5

2349

11436

J01MA14

ATC

moxifloxacin; systemic

1.8

73.4

1315

5408

B01AA03

ATC

warfarin; systemic

1.6

73.3

2260

10902

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

73.2

1126

4384

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

63.2

73.0

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

72.9

5128

29339

E66.8

ICD-10 Finland

Other obesity

2.0

72.7

974

3591

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

72.6

2116

10063

C03AA03

ATC

hydrochlorothiazide; oral

2.0

72.5

1008

3771

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.2

72.3

825

2837

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

74.7

72.2

D07AC13

ATC

mometasone; topical

1.4

72.1

4683

26415

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

72.1

1665

7421

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

71.7

1152

4557

SPAT1053

SPAT

Memory test

2.2

71.6

818

2817

L04AA11

ATC

[U] etanercept; parenteral

11.2

71.5

148

R33

ICD-10 Finland

Retention of urine

2.0

71.5

961

3550

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

71.4

809

2775

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

71.3

1174

4685

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.7

71.2

342

687

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.2

71.2

420

991

R55

ICD-10 Finland

Syncope and collapse

1.8

71.0

1279

5267

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

70.9

1168

4660

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.0

70.8

137

L14

ICPC

Leg/thigh symptom/complaint

2.2

70.7

821

2849

G04BD08

ATC

solifenacin; oral

2.4

70.6

670

2109

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

70.3

2101

10048

R52.0

ICD-10 Finland

Acute pain

2.8

69.8

503

1356

N05BA12

ATC

alprazolam; oral

1.7

69.7

1549

6823

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

69.5

481

1263

R51

ICD-10 Finland

Headache

2.1

69.5

824

2884

A01AB09

ATC

miconazole; local oral

1.9

69.4

1171

4713

D82

ICPC

Teeth/gum disease

1.3

69.2

5752

33757

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

567.9

69.2

M01AE51

ATC

ibuprofen, combinations; systemic

4.6

69.2

265

431

N06AX03

ATC

mianserin; oral

2.3

69.1

708

2316

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

69.1

1946

9164

M75.2

ICD-10 Finland

Bicipital tendinitis

3.2

68.9

403

945

RF410

NOMESCO Finland

5.3

68.8

230

322

R11

ICD-10 Finland

Nausea and vomiting

2.0

68.5

1016

3899

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

68.5

451

1148

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.7

68.5

334

680

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

68.4

1839

8552

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

68.4

1639

7382

M53.9

ICD-10 Finland

Dorsopathy, unspecified

13.0

68.3

132

7214A

ICD-9 Finland

Spondylosis and allied disorders, Thoracic or lumbar spondylosis with myelopathy

+∞

68.3

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

68.2

1198

4889

J01FA15

ATC

telithromycin; oral

1.7

68.2

1750

8035

J05AB01

ATC

aciclovir; systemic

1.5

68.2

3099

16310

K08.80

ICD-10 Finland

Toothache NOS

1.8

67.9

1332

5639

A04

ICPC

Weakness/tiredness general

1.7

67.6

1537

6816

P20

ICPC

Memory disturbance

2.2

67.5

791

2753

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

67.4

999

3832

M05BA04

ATC

alendronic acid; oral

2.4

67.4

646

2044

RF120

NOMESCO Finland

5.3

67.1

225

316

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

33.8

66.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

66.8

543

1573

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

66.7

991

3806

M09AX01

ATC

hyaluronic acid; parenteral

2.7

66.6

499

1379

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.8

66.6

461

1213

M70.7

ICD-10 Finland

Other bursitis of hip

3.9

66.3

296

558

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.3

66.3

692

2285

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

66.2

1827

8551

SPAT1360

SPAT

Extensive global examination

2.0

66.1

876

3215

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

66.1

750

2573

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.9

66.1

1043

4098

D01

ICPC

Abdominal pain/cramps general

1.8

66.0

1329

5673

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

66.0

773

2690

R25.2

ICD-10 Finland

Cramp and spasm

3.6

65.9

333

698

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

65.8

6116

36453

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

65.8

2191

10753

N03AF01

ATC

carbamazepine; oral, rectal

2.1

65.7

794

2801

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

65.7

664

2156

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.7

65.7

311

618

SPAT1104

SPAT

Monitoring of emergency patient

2.1

65.6

820

2937

M75.5

ICD-10 Finland

Bursitis of shoulder

3.4

65.5

353

779

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

16.9

65.3

114

M48

ICD-10 Finland

Other spondylopathies

53.0

65.1

XQ800

NOMESCO Finland

Prick test

1.8

65.1

1227

5128

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

65.1

3511

19095

D11

ICPC

Diarrhoea

1.7

65.0

1669

7658

R01AD01

ATC

beclometasone; nasal

1.5

65.0

2540

12933

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

64.9

1083

4339

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.6

64.9

506

1431

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

64.9

756

2624

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

64.9

2042

9881

OAA65

SPAT

1.6

64.9

2159

10592

C10AC01

ATC

colestyramine; oral

3.0

64.7

402

985

SPAT1210

SPAT

Application of cast or individual aid

2.4

64.6

593

1836

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

64.6

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.5

64.6

564

1701

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

64.4

1234

5183

M77.4

ICD-10 Finland

Metatarsalgia

2.1

64.3

806

2888

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

64.3

1080

4338

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

64.3

1766

8253

A03

ICPC

Fever

1.5

64.1

2476

12574

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

64.0

479

1321

RD211

NOMESCO Finland

2.3

64.0

661

2171

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

64.0

1229

5167

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.1

63.9

380

902

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

63.6

478

1324

C05AA08

ATC

fluocortolone; rectal, topical

1.6

63.3

2127

10454

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

63.3

936

3586

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

63.2

883

3309

XKC03

NOMESCO Finland

Water cystometry

3.3

63.2

356

813

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

63.1

3471

18933

NBG10

NOMESCO Finland

Acromioplastia

3.9

63.0

286

548

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

62.9

570

1751

R74

ICPC

Upper respiratory infection acute

1.4

62.8

4672

26853

H01

ICPC

Ear pain/earache

1.7

62.8

1392

6121

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.1

62.7

376

897

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

62.4

825

3024

SPAT1252

SPAT

Overall medication plan or its review

2.2

62.4

729

2533

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

62.3

724

2511

JAH01

NOMESCO Finland

Laparoscopy

2.2

62.2

730

2544

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.6

62.1

309

640

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

2.2

62.1

699

2389

R03BA08

ATC

ciclesonide; inhalant

1.8

62.0

1208

5099

C09AA02

ATC

enalapril; systemic

1.5

61.9

2361

11947

M77.0

ICD-10 Finland

Medial epicondylitis

2.7

61.8

462

1273

A11

ICPC

Chest pain NOS

2.1

61.6

768

2745

S01FA04

ATC

cyclopentolate; ophthalmic

4.2

61.4

257

457

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

61.3

9255

58830

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.5

61.3

534

1608

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.5

61.2

239

397

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.2

61.1

254

449

L90

ICPC

Osteoarthrosis of knee

2.5

61.0

540

1639

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.3

60.9

337

760

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

60.8

552

1699

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.0

60.8

886

3375

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.9

60.8

414

1078

M10.9

ICD-10 Finland

Gout, unspecified

2.2

60.6

693

2385

H03AA01

ATC

levothyroxine sodium; systemic

1.4

60.6

3026

16188

SPAT1043

SPAT

Audiometry

2.1

60.5

780

2828

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.7

60.4

224

353

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

60.3

1284

5574

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.8

60.3

1191

5049

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

60.3

351

820

M53.8

ICD-10 Finland

Other specified dorsopathies

9.6

60.2

134

103

N06AB06

ATC

sertraline; oral

1.6

60.1

1733

8195

1220

FHL

Arthroscopy

2.2

59.7

649

2184

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

59.7

1456

6580

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

59.7

820

3051

N06AX26

ATC

vortioxetine; oral

1.9

59.7

946

3718

M47

ICD-10 Finland

Spondylosis

10.0

59.6

130

L09

ICPC

Arm symptom/complaint

2.3

59.5

589

1895

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

59.3

987

3948

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

59.3

987

3950

D19

ICPC

Teeth/gum symptom/complaint

1.4

59.2

4168

23703

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

59.2

915

3565

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

58.9

1562

7220

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

58.8

1473

6705

M01AC02

ATC

tenoxicam; systemic, rectal

2.3

58.7

573

1831

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.1

58.6

744

2680

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

245.8

58.6

M25.2

ICD-10 Finland

Flail joint

3.9

58.5

267

514

D07XC01

ATC

betamethasone, combinations; topical

1.6

58.1

1772

8498

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

58.1

781

2882

M22.4

ICD-10 Finland

Chondromalacia patellae

2.3

58.1

582

1884

R21

ICPC

Throat symptom/complaint

1.4

58.0

2916

15609

A02BX02

ATC

sucralfate; oral

2.3

57.9

572

1837

I20.09

ICD-10 Finland

Unstable angina

2.3

57.8

605

1998

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

57.7

713

2538

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

57.7

385

990

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

57.7

1646

7758

L18

ICPC

Muscle pain

2.6

57.6

455

1297

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

103.3

57.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

57.6

1151

4897

SPAT1283

SPAT

Restricted health certificate

1.4

57.6

3262

17851

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.0

57.5

368

920

N17

ICPC

Vertigo/dizziness

1.8

57.5

1031

4235

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.4

57.4

227

382

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

57.3

1603

7516

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

57.3

534

1667

M48.4

ICD-10 Finland

Fatigue fracture of vertebra

55.4

57.3

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.9

57.1

948

3787

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

57.0

537

1684

J46

ICD-10 Finland

Status asthmaticus

2.9

56.9

387

1007

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

56.9

2882

27941

N07CA01

ATC

betahistine; oral

1.9

56.9

865

3347

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.7

56.8

269

535

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

56.8

1247

5463

R31

ICD-10 Finland

Unspecified haematuria

1.8

56.7

1131

4808

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

41.1

56.6

N30.0

ICD-10 Finland

Acute cystitis

1.6

56.3

1504

6967

TAC99

NOMESCO Finland

Other blockade for chronic pain

8.1

56.3

138

126

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.1

56.1

239

433

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.5

55.9

284

599

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

55.9

622

2115

M51

ICD-10 Finland

Other intervertebral disc disorders

10.2

55.6

120

ZXC95

NOMESCO Finland

Use of surgical navigator

4.4

55.5

219

368

UJD02

NOMESCO Finland

Gastroscopy

2.2

55.5

607

2048

C01CA24

ATC

epinephrine; parenteral

1.8

54.9

989

4067

C10AA04

ATC

fluvastatin; oral

2.0

54.7

728

2674

N01

ICPC

Headache

1.7

54.7

1308

5873

R06AX22

ATC

ebastine; oral

1.4

54.6

2827

15199

E000001

ATC

1.4

54.5

3114

17048

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

54.4

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

24.8

54.4

R00.2

ICD-10 Finland

Palpitations

1.9

54.4

923

3716

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.8

54.3

249

482

Z56.5

ICD-10 Finland

Uncongenial work

21.4

54.1

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

54.1

803

3080

S97

ICPC

Chronic ulcer skin

2.3

53.9

561

1850

F34.1

ICD-10 Finland

Dysthymia

2.3

53.8

563

1860

K59.0

ICD-10 Finland

Constipation

2.1

53.8

639

2237

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.8

53.7

195

301

L99

ICPC

Musculoskeletal disease other

3.5

53.5

269

563

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

53.5

905

3642

S80.0

ICD-10 Finland

Contusion of knee

1.8

53.4

926

3759

M50.2

ICD-10 Finland

Other cervical disc displacement

95.9

53.2

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

53.1

1203

5316

K85

ICPC

Elevated blood pressure

1.7

53.1

1329

6042

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

53.1

3818

21731

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

53.1

1484

6953

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

52.9

1276

5741

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

52.9

678

2453

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.1

52.9

317

758

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

52.8

529

1712

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

52.8

867

3450

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

52.8

609

2106

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

52.7

2021

20524

R4110

SPAT

3.0

52.7

331

818

J01DA06

ATC

[U] cefuroxime; systemic

1.5

52.6

2308

12002

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

+∞

52.6

71700

ICD-8 Finland

+∞

52.6

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

52.6

500

1577

K04.0

ICD-10 Finland

Pulpitis

1.5

52.5

1782

8758

SPAT1106

SPAT

Acupuncture

6.7

52.5

145

159

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

52.2

498

1574

N62

ICD-10 Finland

Hypertrophy of breast

2.1

52.2

652

2333

A07AA02

ATC

nystatin; oral

2.0

52.0

683

2495

M67.4

ICD-10 Finland

Ganglion

1.8

51.9

932

3828

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

23.0

51.4

Z02.4

ICD-10 Finland

Examination for driving licence

1.5

51.3

2178

11248

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

51.2

2073

10597

M23.8

ICD-10 Finland

Other internal derangements of knee

2.1

51.1

597

2075

G04CB02

ATC

dutasteride; oral

2.2

51.0

564

1913

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

51.0

1129

4954

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

7.6

50.9

130

127

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

50.8

2513

13378

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

50.8

564

1916

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.5

50.7

424

1249

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

22.7

50.6

D06

ICPC

Abdominal pain localized other

1.8

50.4

920

3798

J04AB02

ATC

rifampicin; systemic

4.4

50.3

200

339

L20

ICPC

Joint symptom/complaint NOS

2.5

50.3

445

1351

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.6

50.2

388

1092

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

5.1

50.0

173

253

XF404

NOMESCO Finland

Ambulatory ECG

1.8

50.0

995

4223

R09

ICPC

Sinus symptom/complaint

1.7

50.0

1062

4600

N41.1

ICD-10 Finland

Chronic prostatitis

2.9

49.9

338

878

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

15.7

49.9

R39.1

ICD-10 Finland

Other difficulties with micturition

2.7

49.8

379

1057

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

49.8

1290

5919

K05.30

ICD-10 Finland

Periodontitis complex

1.6

49.8

1608

7806

L60.0

ICD-10 Finland

Ingrowing nail

2.2

49.7

540

1816

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.3

49.7

522

1728

M15.8

ICD-10 Finland

Other polyarthrosis

4.3

49.6

200

344

R07.0

ICD-10 Finland

Pain in throat

1.8

49.5

862

3502

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

49.4

484

1548

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

49.3

646

2359

SPAT1081

SPAT

Cardiorespiratory global assessment

2.3

49.2

501

1634

C09DA01

ATC

losartan and diuretics; oral

1.7

49.2

1166

5220

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.9

49.1

330

853

L10

ICPC

Elbow symptom/complaint

2.0

49.1

719

2742

M19.2

ICD-10 Finland

Other secondary arthrosis

4.2

49.1

205

365

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

10.9

49.0

102

ICD-10 Finland

2.8

49.0

340

896

H02

ICPC

Hearing complaint

1.8

49.0

877

3595

K86

ICPC

Hypertension uncomplicated

1.8

49.0

922

3845

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

48.9

K08.3

ICD-10 Finland

Retained dental root

1.8

48.8

952

4016

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.2

48.6

285

671

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

48.5

1753

8735

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

2.8

48.4

345

926

M41.8

ICD-10 Finland

Other forms of scoliosis

18.7

48.3

XCK00

NOMESCO Finland

Perimetry

1.9

48.1

742

2887

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

48.0

670

2510

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

48.0

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.7

48.0

1128

5037

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.6

48.0

384

1103

OAB93

SPAT

2.1

47.7

604

2174

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.1

47.7

201

361

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

47.6

751

2944

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

47.6

1409

6691

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

47.5

1706

8488

UDC00

NOMESCO Finland

Ear microscopy

1.8

47.5

875

3622

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

47.5

1136

5096

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

47.4

647

2401

S21

ICPC

Skin texture symptom/complaint

1.6

47.4

1282

5948

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

47.2

1382

6545

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

37.5

47.2

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

4.3

47.1

192

334

A07EC02

ATC

mesalazine; oral, rectal

1.8

47.1

898

3761

7244A

ICD-9 Finland

Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified

+∞

47.0

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

47.0

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

47.0

465

1494

-50

ICPC

Medication/prescr/renewal

2.2

47.0

514

1736

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

46.9

1306

6106

M41.2

ICD-10 Finland

Other idiopathic scoliosis

46.4

46.9

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

46.8

400

1194

R51.81

ICD-10 Finland

Facial pain NOS

2.9

46.8

311

799

L89

ICPC

Osteoarthrosis of hip

3.1

46.7

278

663

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

46.7

1007

4383

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

46.5

517

1756

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

46.3

916

3883

G50.1

ICD-10 Finland

Atypical facial pain

3.4

46.2

246

540

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

46.1

SBB10

NOMESCO Finland

Teeth copy

1.8

46.1

868

3619

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

4.9

46.1

163

245

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

46.1

567

2016

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.9

46.0

755

3004

S15

ICPC

Foreign body in skin

1.9

46.0

699

2705

U02

ICPC

Urinary frequency/urgency

1.6

45.9

1216

5613

S83.2

ICD-10 Finland

Tear of meniscus, current

1.7

45.8

1134

5138

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

5.1

45.8

156

225

A06AC51

ATC

ispaghula, combinations; systemic

2.1

45.7

589

2136

TQW40

SPAT

2.4

45.6

418

1293

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

45.6

667

2542

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

45.5

648

2445

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

45.5

646

2435

M75

ICD-10 Finland

Shoulder lesions

2.1

45.4

575

2070

NA3AA

SPAT

2.5

45.3

374

1093

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

45.2

634

2379

R01AD11

ATC

triamcinolone; nasal

1.6

45.2

1342

6377

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

+∞

45.2

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

45.2

589

2145

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

45.1

766

3084

SPAT1285

SPAT

Provision of consultation response

2.1

45.0

568

2043

D02

ICPC

Abdominal pain epigastric

2.0

44.9

650

2469

R03AC13

ATC

formoterol; inhalant

2.0

44.9

664

2543

R06AE09

ATC

levocetirizine; oral

1.4

44.8

2282

12194

N07BC02

ATC

methadone; systemic

11.9

44.7

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

44.6

878

3713

ZX140

NOMESCO Finland

Intra articular

4.9

44.6

158

238

J45.8

ICD-10 Finland

Mixed asthma

2.4

44.4

407

1260

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

44.3

1291

6105

71319

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis NUD

+∞

44.3

K80

ICPC

Cardiac arrhythmia NOS

1.9

44.3

675

2615

J01MA06

ATC

norfloxacin; oral

1.5

44.2

1812

9272

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

68.9

44.2

H53.2

ICD-10 Finland

Diplopia

2.5

44.2

371

1097

RF220

NOMESCO Finland

3.7

44.1

209

418

G56.4

ICD-10 Finland

Causalgia

8.4

44.1

105

SPAT1059

SPAT

Spirometry at the office

2.1

44.0

563

2034

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

44.0

874

3707

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

44.0

1069

4815

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

3.0

43.9

273

671

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

5.8

43.9

135

172

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.9

43.9

285

721

M01CB01

ATC

sodium aurothiomalate; parenteral

3.7

43.9

208

416

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.8

43.8

305

806

H02.3

ICD-10 Finland

Blepharochalasis

2.1

43.7

550

1976

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

40.2

43.5

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

43.5

486

1656

R25.1

ICD-10 Finland

Tremor, unspecified

2.8

43.4

300

790

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

43.4

578

2125

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

4.0

43.2

187

345

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

184.5

43.1

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.1

43.1

527

1869

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

43.0

527

1872

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

43.0

265

647

1412

FHL

Laparoscopy and sterilization

2.3

43.0

417

1329

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

42.9

559

2035

J01

ICD-10 Finland

Acute sinusitis

1.9

42.9

689

2720

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

42.9

675

2644

H93.1

ICD-10 Finland

Tinnitus

1.8

42.8

810

3382

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.9

42.8

724

2911

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

29.0

42.7

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

42.6

501

1747

C08CA02

ATC

felodipine; oral

1.8

42.5

864

3690

A10BH01

ATC

sitagliptin; oral

1.7

42.5

962

4246

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

42.4

968

4282

R12

ICD-10 Finland

Heartburn

1.8

42.4

842

3573

L04

ICPC

Chest symptom/complaint

1.9

42.3

627

2402

C08CA05

ATC

nifedipine; systemic

1.8

42.1

813

3419

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

42.0

325

917

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.4

42.0

377

1155

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

6.9

41.8

113

121

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

41.8

1865

9707

L04AX01

ATC

azathioprine; systemic

1.9

41.8

666

2623

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

41.5

1882

9824

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

41.5

L92

ICPC

Shoulder syndrome

2.9

41.5

278

719

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

41.5

673

2665

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

41.3

334

968

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

41.2

800

3369

P01

ICPC

Feeling anxious/nervous/tense

1.5

41.2

1408

6917

H13

ICPC

Plugged feeling ear

1.5

41.2

1716

8808

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

41.1

474

1638

G03DC02

ATC

norethisterone; oral

1.6

41.1

1102

5097

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

41.0

282

741

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

41.0

755

3125

S01

ICPC

Pain/tenderness of skin

2.2

41.0

463

1586

Y6099

ICD-8 Finland

Prenatal care and observation

2.5

40.9

347

1032

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

40.9

925

4081

A02BA03

ATC

famotidine; systemic

2.1

40.9

497

1758

N03AX11

ATC

topiramate; oral

2.3

40.8

414

1350

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.1

40.8

248

601

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.5

40.7

340

1003

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.4

40.6

368

1133

A99

ICPC

Disease/condition unspecnature/site

1.7

40.6

858

3708

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

40.6

292

790

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

40.5

747

3092

M24.2

ICD-10 Finland

Disorder of ligament

2.9

40.5

261

658

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

5.8

40.4

124

158

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

40.4

622

2419

Z30.2

ICD-10 Finland

Sterilization

1.4

40.3

2211

11960

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

40.3

756

3148

M01AB16

ATC

aceclofenac; oral

2.3

40.3

409

1333

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

40.3

1750

9054

Z37.0

ICD-10 Finland

Single live birth

0.6

40.3

636

7748

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

40.2

843

3636

S04

ICPC

Lump/swelling localized

1.6

40.2

1020

4649

R10.0

ICD-10 Finland

Acute abdomen

2.2

40.2

436

1466

M17.5

ICD-10 Finland

Other secondary gonarthrosis

3.5

40.1

203

429

N06AA06

ATC

trimipramine; systemic

2.4

40.1

356

1084

TNG10

NOMESCO Finland

Puncture of knee

3.9

40.0

181

348

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

40.0

234

552

1410

FHL

Laparoscopy

2.3

40.0

412

1352

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.7

39.9

302

842

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

14.0

39.9

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

39.8

554

2071

T82

ICPC

Obesity

2.0

39.8

564

2124

G04BD07

ATC

tolterodine; oral

2.1

39.7

502

1805

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

39.7

618

2412

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.0

39.7

248

613

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

4.2

39.7

165

294

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

2.4

39.6

362

1120

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

39.6

906

4010

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

39.6

1671

8595

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

39.5

870

3806

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

39.5

375

1183

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.1

39.4

239

578

M13.8

ICD-10 Finland

Other specified arthritis

3.9

39.4

174

328

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

39.3

352

1078

A98

ICPC

Health maint/preventive medicine

1.3

39.3

18272

129039

ZA1.0

ICD-10 Finland

Shoulder region

2.8

39.2

267

698

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

39.2

800

3422

NA2AD

NOMESCO Finland

Thoracic spine CT examination

7.9

39.2

K04.08

ICD-10 Finland

Other specified pulpit

1.6

39.0

1134

5356

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.1

38.9

233

559

NA3CG

SPAT

4.1

38.9

162

289

RS221

NOMESCO Finland

3.0

38.9

239

584

A07DA03

ATC

loperamide; oral

2.1

38.9

474

1680

M13.0

ICD-10 Finland

Polyarthritis, unspecified

3.6

38.9

188

383

SPAT1281

SPAT

Other administrative function

1.7

38.9

922

4122

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.3

38.8

397

1301

A01AB04

ATC

amphotericin B; local oral

2.0

38.8

552

2083

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

+∞

38.7

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.3

38.7

210

469

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

20.2

38.7

1221

FHL

Arthroscopy and meniscus surgery

2.4

38.7

355

1100

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.7

38.6

886

3924

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5224

17828

1.87

322.70

2.2

2.3

nmol/l

350.8

380.7

19.27

4773

16451

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3928

12137

2.05

322.13

7.1

7.3

mmol/l

24.9

24.5

7.94

3656

11307

(3017181) Myelocytes/100 leukocytes in Blood

5187

17824

1.86

313.13

4.3

4.1

0.9

1.0

1.46

1373

5105

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8665

34544

1.64

311.18

3.1

3.5

mmol/l

0.8

2.80

8007

32280

(3009508) Creatinine [Moles/volume] in Urine

15520

68028

1.57

307.65

3.2

mmol/l

7.5

7.7

6.58

13006

57117

(3026008) Bacteria identified in Urine by Culture

15297

60270

1.79

307.65

3.6

2.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11893

44766

1.81

307.65

1.8

1.7

mg/l

1.1

1.3

11.34

9240

34391

(3019060) Gas panel - Arterial blood

4236

12792

2.11

307.65

4.6

5.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

6955

24095

1.88

307.65

1.9

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

8647

33773

1.68

307.65

2.6

2.5

umol/l

12.7

13.1

4.55

7947

31288

(3020630) Protein [Mass/volume] in Serum or Plasma

5089

16267

2.01

307.65

2.6

2.5

g/l

66.7

66.3

3.30

4624

14806

(3020564) Creatinine [Moles/volume] in Serum or Plasma

44199

244872

2.17

307.65

22.1

15.0

umol/l

79.1

78.0

7.20

44190

244732

(3011397) Hemoglobin [Presence] in Urine by Test strip

12888

46631

1.93

307.65

4.5

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9043

35770

1.66

307.65

3.0

2.7

e6/l

1.1

1.2

0.89

5696

19692

(36304419) Bacteria [Presence] in Urine

14175

56990

1.72

307.65

3.5

2.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

32863

148597

2.08

307.65

5.3

3.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

43760

234659

2.46

307.65

21.4

14.8

mmol/l

139.5

139.7

36.36

43083

228025

(40761535) Cells panel - Urine sediment

5472

15452

2.30

307.65

4.2

3.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

39505

209438

1.81

307.65

6.7

5.4

mmol/mol

40.3

39.7

30.72

36911

193536

(3032080) INR in Blood by Coagulation assay

21255

86871

1.87

307.65

9.0

8.8

inr

1.2

1.3

5.46

6421

24917

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

43969

245837

1.99

307.65

13.6

9.6

u/l

26.5

26.7

1.15

42776

236848

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

34193

168894

1.79

307.65

4.4

3.8

pmol/l

14.9

14.7

21.82

31262

153522

(40760892) CBC W Ordered Manual Differential panel - Blood

12002

47146

1.73

307.65

5.2

4.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

31430

139611

2.06

307.65

5.5

3.9

e6/l

1328.5

1323.8

0.00

360

2126

(3021589) Normoblasts [#/volume] in Blood

21398

98232

1.58

307.65

11.6

9.2

e9/l

0.0

0.46

18269

80042

(3020682) Albumin/Creatinine [Ratio] in Urine

15470

68112

1.56

307.65

4.0

mg/mmol

9.2

0.01

9855

43157

(3015377) Calcium [Moles/volume] in Serum or Plasma

16942

71766

1.67

307.65

3.0

3.6

mmol/l

2.4

0.12

14784

62681

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7158

25058

1.86

307.65

8.6

6.6

—

(40758558) Short blood count panel - Blood

13003

54411

1.62

307.65

6.9

7.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6466

22065

1.90

307.65

1.9

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9658

38015

1.68

307.65

2.8

3.2

mmol/l

2.5

0.59

8437

33111

(3042936) Bacteria identified in Isolate by Culture

8263

29507

1.85

307.65

2.2

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10702

33095

2.24

307.65

1.3

1.2

iu/ml

32.1

42.1

2.90

3365

10732

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17553

61437

2.16

307.65

2.4

2.0

u/l

200.1

220.4

1.45

16477

57484

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6813

23439

1.89

307.65

6.4

7.7

kpa

5.1

4.64

6487

22357

(3012516) Albumin [Mass/volume] in Urine

14882

64378

1.58

307.65

3.3

mg/l

616.9

318.7

8.06

9583

40545

(3022217) INR in Platelet poor plasma by Coagulation assay

7390

27484

1.75

307.65

24.6

24.3

inr

1.3

1.4

1.79

980

3911

(3019069) Monocytes/100 leukocytes in Blood

23556

102001

1.79

307.65

7.7

6.1

8.7

8.6

0.43

22206

95493

(42870588) Differential panel, method unspecified - Blood

18219

72916

1.83

307.65

6.8

5.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17167

64977

1.94

307.65

2.7

2.5

u/l

56.5

59.7

6.47

15895

59802

(3037522) Nuclear Ab [Titer] in Serum

8635

27096

2.14

307.65

1.4

1.3

titre

508.5

552.6

1.20

1760

5568

(3018418) pH of Serum or Plasma

15737

61816

1.81

307.65

4.3

4.1

7.4

0.43

3116

12254

(3018095) Leukocytes [#/volume] in Urine

17955

75189

1.72

307.65

4.1

3.5

e6/l

86.2

110.1

2.61

13508

52351

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

39848

216783

1.67

307.65

16.9

12.3

ml/min/173m2

79.8

81.1

27.59

34497

177894

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10259

30875

2.29

307.65

1.3

1.2

u/ml

10.5

13.9

3.05

4144

12128

(3002030) Lymphocytes/100 leukocytes in Blood

23864

105086

1.75

307.65

7.4

5.9

27.9

27.6

3.56

22377

97865

(3004588) Protein electrophoresis panel - Serum or Plasma

4446

13047

2.18

307.65

2.5

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

20695

86942

1.78

307.65

2.1

1.9

pmol/l

95.3

95.7

0.65

11046

45634

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

43244

226478

2.57

307.65

19.7

12.8

mg/l

22.3

24.9

48.02

36957

176383

(3013115) Eosinophils [#/volume] in Blood

26772

110469

2.06

307.65

7.1

5.9

e9/l

0.2

6.84

24120

96153

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9124

32700

1.86

307.65

2.0

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

24490

99430

2.01

307.65

4.5

3.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5656

19180

1.90

307.65

7.0

8.6

g/l

121.7

121.2

0.97

5451

18509

(3001604) Monocytes [#/volume] in Blood

26043

106320

2.06

307.65

7.0

5.7

e9/l

0.6

0.95

23208

91215

(3021960) Folate [Moles/volume] in Serum or Plasma

12271

47450

1.77

307.65

1.6

1.5

nmol/l

20.3

20.2

0.09

10609

40694

(3003396) Base excess in Arterial blood by calculation

6770

23480

1.87

307.65

6.4

7.7

mmol/l

1.2

0.9

5.10

5331

18562

(3019150) Specific gravity of Urine by Refractometry

11998

42751

1.94

307.65

5.1

3.6

kg/l

1.0

0.42

1766

6748

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2543

5904

2.71

307.65

1.6

iu/ml

10.0

5.3

0.33

604

1194

(3002582) Erythrocytes [#/volume] in Urine

15474

64598

1.67

307.65

3.6

3.1

e6/l

82.1

100.9

0.73

12468

48701

(3019309) Folate [Moles/volume] in Red Blood Cells

10564

38290

1.87

307.65

1.8

1.7

nmol/l

1221.5

1149.0

11.56

8128

28690

(40761511) CBC panel - Blood by Automated count

43262

238823

1.99

307.65

18.1

12.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5328

16882

2.03

307.65

2.6

2.2

ug/l

6.0

8.2

9.21

4602

14650

(3026782) Osmolality of Urine

10276

41517

1.64

307.65

3.0

2.7

mosm/kgh2o

526.3

553.1

7.42

8841

35232

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

37163

169746

2.44

307.65

8.5

7.3

u/l

77.4

79.1

9.27

35392

159416

(3027801) Oxygen [Partial pressure] in Arterial blood

6808

23425

1.89

307.65

6.4

7.7

kpa

12.2

12.5

4.74

6479

22335

(3044640) Blood type and Crossmatch panel - Blood

16822

67354

1.79

307.65

2.6

2.3

—

(3044889) 12 lead EKG panel

32276

157130

1.75

307.65

4.5

3.5

—

(3018010) Neutrophils/100 leukocytes in Blood

23569

103366

1.75

307.65

7.2

5.7

57.1

57.6

6.67

22174

96715

(40768797) Stomach Pathology biopsy report

7898

28022

1.85

307.65

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

25906

112327

1.87

307.65

5.8

6.3

umol/l

10.6

11.8

47.64

24563

106390

(3035350) Ketones [Presence] in Urine by Test strip

24962

103775

1.96

307.65

4.5

3.3

estimate

0.0

0.28

5037

19287

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19341

80812

1.76

307.65

4.8

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

24899

104283

1.93

307.65

5.7

4.5

estimate

0.0

0.48

5154

19680

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

40777

220816

1.79

307.65

5.2

4.3

mmol/l

6.0

5.9

37.89

37445

201753

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13455

51699

1.81

307.65

2.5

2.2

mg/l

3.0

0.65

11660

43864

(3008898) HLA-B27 [Presence]

2773

5294

3.31

307.65

1.1

1.0

—

(3022096) Basophils/100 leukocytes in Blood

22837

98424

1.78

307.65

7.4

5.9

0.7

3.77

21445

91759

(3019198) Lymphocytes [#/volume] in Blood

26461

109789

2.03

307.65

7.1

5.7

e9/l

1.9

1.99

23918

95885

(3013650) Neutrophils [#/volume] in Blood by Automated count

28828

124584

2.01

307.65

9.4

9.3

e9/l

4.2

4.1

3.59

25935

107977

(3013707) Erythrocyte sedimentation rate by Westergren method

36776

159798

2.68

307.65

5.6

3.6

mm/h

12.6

12.2

6.66

34668

147186

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

20331

79518

1.96

307.65

4.3

3.2

ng/l

61.5

68.3

0.12

14634

53028

(3048689) Calprotectin [Mass/mass] in Stool

6559

23781

1.78

307.65

2.4

ug/g

146.9

139.2

0.63

5228

18726

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

20214

87584

1.69

307.65

2.5

2.2

nmol/l

78.1

77.0

5.19

18259

78677

(3016502) Oxygen saturation in Arterial blood

6154

20745

1.92

307.65

6.6

8.2

95.8

95.5

2.06

5912

19988

(3006504) Eosinophils/100 leukocytes in Blood

23423

101477

1.78

307.65

7.3

5.8

2.9

2.8

2.03

22010

94530

(3024561) Albumin [Mass/volume] in Serum or Plasma

22356

92597

1.87

307.65

4.8

g/l

35.5

35.4

1.71

20741

85783

(3029937) Albumin [Presence] in Urine by Test strip

14826

54497

1.94

307.65

5.1

3.6

estimate

0.0

0.09

4987

18707

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

23452

95126

1.97

307.65

6.3

6.0

mmol/l

1.2

2.96

21461

85944

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6439

22012

1.90

307.65

1.8

1.7

—

(3006315) Basophils [#/volume] in Blood

26146

106863

2.06

307.65

7.0

5.7

e9/l

0.0

13.53

23296

91676

(3015736) pH of Urine

19679

80117

1.83

307.65

4.2

3.1

5.6

5.8

0.36

(3033658) Prothrombin time (PT) actual/Normal

13080

55661

1.59

307.65

4.1

3.9

91.1

89.7

6.89

12656

54386

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

39436

205680

1.91

307.65

5.3

4.4

mu/l

2.0

2.2

0.85

36424

187855

(3030467) Casts [#/volume] in Urine by Automated count

14575

58643

1.73

307.65

3.5

3.0

e6/l

0.4

0.5

4.81

11574

43248

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12883

50888

1.73

307.65

2.5

2.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

43804

235488

2.44

307.65

21.5

14.9

mmol/l

4.0

46.93

43093

228398

(3013826) Glucose [Moles/volume] in Serum or Plasma

29577

125902

2.11

307.65

5.1

4.6

mmol/l

6.7

6.8

12.78

28247

117428

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11197

44745

1.68

307.65

1.8

1.7

pmol/l

31837652.2

31043598.7

0.05

9313

36926

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15788

58604

1.95

307.65

3.1

2.9

ng/l

1211.3

1541.9

18.09

13600

49877

(3023368) Bacteria identified in Blood by Culture

14609

57700

1.77

307.65

4.8

4.2

—

(3000850) Epithelial cells [#/volume] in Urine

11821

43326

1.87

307.65

2.8

2.5

e6/l

4.8

5.4

6.07

10448

37676

(3001122) Ferritin [Mass/volume] in Serum or Plasma

20136

92012

1.57

307.65

3.1

2.7

ug/l

135.2

135.9

0.11

18522

85267

(3009261) Glucose [Presence] in Urine by Test strip

25178

105388

1.94

307.65

4.5

3.3

estimate

0.0

0.22

4990

19074

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

25577

105518

2.01

307.65

6.9

6.6

mmol/l

1.2

2.43

21649

88182

(3026493) Urate [Moles/volume] in Serum or Plasma

14805

56956

1.84

307.65

2.7

2.6

umol/l

3664.5

4867.8

2.87

12765

49723

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10669

43914

1.61

307.65

1.3

1.2

u/ml

1.3

1.9

4.90

3080

11819

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2753

7227

2.39

307.65

1.3

1.2

u/ml

1.1

0.9

0.37

318

507

(3000475) Leukocytes [#/volume] in Synovial fluid

1919

4435

2.70

300.16

1.8

1.6

e6/l

12590.5

14319.2

0.74

1429

3203

(3025159) Blasts/100 leukocytes in Blood

4706

15919

1.88

297.20

4.4

4.1

0.2

0.05

1081

4027

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9762

40465

1.58

297.17

4.4

3.4

ng/l

303.5

620.8

10.12

7650

31374

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4862

16633

1.86

296.59

2.7

2.6

ml/min/173m2

65.4

65.2

0.13

1971

6448

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4366

14429

1.92

295.51

1.7

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

4930

16990

1.85

293.78

4.3

4.1

0.1

0.37

1253

4766

(3002179) Metamyelocytes/100 leukocytes in Blood

4744

16150

1.87

293.63

4.0

3.9

0.6

0.7

1.71

1007

3717

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7907

31244

1.64

291.81

2.6

2.5

g/l

2.3

3.24

7274

28807

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2070

5110

2.53

284.52

1.5

1.4

—

(3013512) EKG study

13934

62993

1.48

282.27

4.4

3.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7419

29128

1.65

279.45

2.6

21.9

22.9

6.51

6264

25036

(3027945) Reticulocytes/100 erythrocytes in Blood

6216

23555

1.69

266.59

2.3

2.5

1.8

2.13

5469

20809

(3007164) IgA [Mass/volume] in Serum or Plasma

9283

38944

1.55

263.86

1.5

1.4

g/l

2.5

0.79

5704

24017

(3020891) Body temperature

2645

7560

2.19

262.51

5.0

—

(3023520) Reticulocytes [#/volume] in Blood

4841

17225

1.79

258.21

2.4

2.6

e9/l

69.9

68.9

0.99

3728

12850

(4010399)

4181

14241

1.86

256.50

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6793

26650

1.64

254.26

6.7

7.4

mmol/l

104.2

104.5

7.01

6644

26082

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

41513

232677

1.61

253.88

5.6

4.6

mmol/l

2.7

2.8

119.63

38447

214660

(3005719) IgG [Mass/volume] in Serum or Plasma

4370

15189

1.82

251.24

2.8

2.6

g/l

10.3

10.7

7.44

3967

13896

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15406

72323

1.43

249.00

3.3

3.2

u/l

33.0

34.5

1.92

14562

68495

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6999

27821

1.62

248.03

5.4

6.1

mmol/l

1.0

0.24

6476

25940

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3958

13435

1.86

244.89

2.5

2.3

au/ml

32.8

23.1

2.59

146

895

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7958

32737

1.57

243.99

2.0

2.1

29.9

0.20

7717

31804

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5779

22051

1.67

239.48

3.8

3.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3834

13003

1.86

237.52

7.6

9.9

93.9

0.15

3817

12957

(3007461) Platelets [#/volume] in Blood

44846

257438

1.85

235.24

28.7

18.9

e9/l

252.5

250.5

8.52

44159

249773

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3638

12175

1.88

234.66

1.3

au/ml

59.5

49.8

1.05

118

579

(3000494) Fungus identified in Specimen by Culture

6243

24449

1.63

233.53

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15979

76253

1.41

231.11

5.1

4.7

ug/l

3.0

3.4

0.83

14373

68389

(3014111) Lactate [Moles/volume] in Serum or Plasma

4982

18425

1.72

230.98

6.0

7.4

mmol/l

1.3

1.4

1.03

4800

17749

(3035941) MCH [Entitic mass]

44848

257645

1.83

230.25

28.5

18.8

30.5

30.3

63.17

44437

253495

(3010813) Leukocytes [#/volume] in Blood

44861

257745

1.84

230.19

28.7

18.9

e9/l

6.9

6.7

77.35

44075

249253

(3024731) MCV [Entitic volume]

44848

257687

1.83

229.16

28.6

18.8

91.6

90.9

196.78

44435

253524

(3026361) Erythrocytes [#/volume] in Blood

44850

257709

1.83

228.98

28.7

18.9

e12/l

4.4

4.5

204.17

44070

249192

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3798

12990

1.84

228.79

7.6

9.7

1.4

1.3

7.70

3764

12901

(3000963) Hemoglobin [Mass/volume] in Blood

44851

257795

1.83

226.95

28.8

19.0

g/l

134.2

136.1

128.40

44434

253659

(3018405) Lactate [Moles/volume] in Arterial blood

2332

6711

2.17

226.85

4.2

4.3

mmol/l

1.3

1.4

1.62

2287

6592

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

40720

228544

1.53

224.17

5.0

4.2

mmol/l

4.6

4.7

97.77

37903

212055

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3772

12992

1.83

221.92

7.7

9.9

0.7

7.96

3740

12910

(3022145) Colonoscopy Study observation

6131

24186

1.62

221.79

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

484

510

5.81

213.86

1.7

1.9

mg/l

9.1

9.4

0.43

380

406

(3043409) Potassium [Moles/volume] in Arterial blood

2049

5732

2.22

213.15

4.5

4.6

mmol/l

3.9

1.74

1964

5330

(3021788) Differential panel - Synovial fluid

1455

3496

2.57

210.26

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

12605

58490

1.42

208.70

3.9

3.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

40371

226915

1.50

208.47

4.9

4.2

mmol/l

1.4

1.5

28.18

37337

209607

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4179

15114

1.74

208.39

3.6

4.0

ng/l

89.3

95.5

3.34

3605

12984

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2035

5843

2.16

198.55

1.7

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

34695

190221

1.39

197.64

22.3

15.9

13.8

13.7

38.55

34186

185744

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3392

11711

1.82

197.08

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1448

3605

2.48

194.65

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

39118

219282

1.44

192.90

4.4

3.8

mmol/l

1.4

1.3

69.84

35918

201407

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28601

152636

1.34

188.28

3.5

2.9

u/l

54.8

48.9

16.31

26621

142641

(3044941) Cell count panel - Synovial fluid

1232

2878

2.64

187.89

1.5

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12770

60387

1.39

184.77

4.5

4.0

21.9

0.23

6182

28611

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

404

414

5.97

183.16

1.6

au/ml

155.8

118.5

0.46

(3045414) Leukocytes [Presence] in Urine

2662

8701

1.91

182.75

2.0

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5979

24459

1.55

182.56

3.6

4.3

u/l

240.5

245.4

1.32

5606

23185

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4460

17158

1.64

175.42

3.0

2.8

ng/l

181.7

227.2

9.57

4099

15587

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2370

7567

1.95

174.02

2.5

2.1

g/l

7.4

0.79

1731

5669

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2363

7541

1.95

173.74

2.5

2.1

g/l

3.8

3.9

2.66

1662

5404

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2366

7560

1.95

173.33

2.5

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7775

34077

1.46

169.55

3.3

2.8

e6/l

2.6

0.02

4478

18089

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1046

2387

2.70

166.65

1.6

56.8

58.1

0.40

625

1550

(3000991) Gas panel - Venous blood

4536

17764

1.61

165.56

7.3

8.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3323

11988

1.73

165.46

1.8

1.9

g/l

1.2

1.3

5.16

3018

10932

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2220

7100

1.94

161.97

2.5

2.1

g/l

3.0

3.1

1.57

1691

5560

(3012544) pH of Venous blood

4997

20174

1.56

160.08

3.7

3.9

7.4

0.13

109

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4851

19460

1.57

159.73

3.8

3.9

kpa

5.9

5.8

5.28

4721

18883

(3002032) Base excess in Venous blood by calculation

4840

19412

1.57

159.49

3.8

3.9

mmol/l

2.0

1.8

2.76

3971

15892

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1847

5566

2.06

158.74

1.5

1.4

ug/g

275.2

267.0

0.88

1085

3266

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2619

8951

1.82

156.03

1.3

1.6

u/ml

11.0

16.5

1.59

281

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

847

1783

2.92

155.93

1.5

1.6

32.4

30.2

0.82

513

1130

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3268

11952

1.71

154.59

1.8

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2187

7085

1.92

153.52

2.5

2.1

g/l

9.9

10.4

4.92

1813

5949

(3009343) pH of Capillary blood

3444

12802

1.68

153.47

3.7

3.5

7.4

0.20

496

1692

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3474

12973

1.67

152.12

3.7

3.5

kpa

5.2

5.1

3.08

3207

11967

(3034860) Kappa light chains.free [Mass/volume] in Serum

1996

6287

1.97

151.92

3.6

3.1

mg/l

80.6

56.2

0.39

1582

5077

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1992

6274

1.97

151.63

3.7

3.1

mg/l

38.3

43.5

0.72

1578

5067

(3025941) Bacteria identified in Stool by Culture

3191

11659

1.71

151.37

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

18022

91827

1.31

150.50

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

3310

12249

1.69

149.82

1.3

u/ml

207.6

275.5

2.78

3062

11347

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2995

10798

1.73

148.89

2.5

2.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2174

7111

1.90

148.21

2.2

2.3

ug/l

406.6

624.1

2.39

2038

6694

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3321

12351

1.68

147.48

3.7

3.4

mmol/l

1.9

1.7

1.77

2455

9106

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1934

6101

1.96

146.48

3.6

3.1

ratio

2.1

5.9

1.56

177

451

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5766

24508

1.49

144.50

2.7

2.8

umol/l

7.4

9.4

8.41

4955

21356

(3024354) Oxygen [Partial pressure] in Venous blood

4019

15775

1.60

144.25

3.2

kpa

4.6

1.11

3894

15228

(40760888) Immunoglobulin light chains.free panel - Serum

1577

4646

2.10

143.58

3.6

3.2

—

(21494755) Public health laboratory ask at order entry panel

2478

25049

0.58

142.78

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4413

17751

1.56

142.63

4.0

3.8

mmol/l

1.2

0.41

3874

15508

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

216

140

9.41

138.70

1.7

1.6

mg/l

1.6

1.7

0.25

183

115

(3010144) Erythrocytes [#/volume] in Synovial fluid

786

1696

2.84

138.59

1.4

e6/l

77210.1

121274.7

1.28

560

1153

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1988

6456

1.91

138.29

2.7

2.3

g/l

0.9

0.47

1720

5504

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

533

904

3.61

137.06

1.4

u/l

5.5

6.5

1.19

449

760

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1775

5638

1.95

131.62

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2354

8241

1.77

128.99

2.0

1.9

ug/l

2.0

2.3

0.34

2054

7265

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2068

6962

1.84

128.70

2.7

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1874

6115

1.90

128.36

1.6

g/l

1.2

2.61

1780

5818

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2058

6957

1.83

126.38

1.6

titre

252.0

289.8

0.26

292

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3007

11344

1.65

125.77

8.3

10.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1820

5930

1.90

125.17

1.6

1.7

g/l

0.2

0.33

1724

5617

(3037756) Immunofixation for Serum or Plasma

1381

4093

2.08

123.64

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1719

5523

1.92

123.20

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3333

12971

1.60

123.05

6.0

7.4

mmol/l

25.0

24.7

3.96

3306

12840

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11877

58389

1.31

122.35

1.7

1.6

mmol/l

1.4

14.42

9828

48971

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1120

3068

2.25

121.72

1.3

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1725

5572

1.91

121.68

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1727

5586

1.91

121.33

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3426

13483

1.58

120.63

1.2

—

(4034850)

1923

6460

1.84

120.35

11.4

9.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2580

9457

1.69

120.09

2.9

1.4

1.2

6.40

2565

9407

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1746

5738

1.88

116.90

2.5

2.1

g/l

0.0

0.07

1603

5210

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2404

8710

1.71

116.64

1.9

2.0

u/l

39.3

0.05

2133

7698

(3022621) pH of Urine by Test strip

3406

13491

1.57

116.52

3.3

2.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3198

12541

1.59

114.05

3.3

g/l

128.6

129.0

0.43

3110

12279

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2511

9276

1.68

113.40

2.8

2.9

0.7

0.03

2386

8952

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1778

5938

1.85

113.24

2.4

2.1

g/l

37.8

37.5

1.35

1548

5054

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4638

19767

1.47

112.65

2.7

2.4

u/l

46.4

47.0

0.02

3936

16986

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1870

6360

1.82

112.41

1.8

1.7

—

(3047181) Lactate [Moles/volume] in Blood

1816

6130

1.83

111.81

5.7

6.1

mmol/l

1.3

2.13

1599

5398

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1654

5421

1.88

111.59

1.3

1.2

u/ml

26.6

40.0

1.26

345

(40761536) Microorganisms panel - Urine sediment

4404

18650

1.48

110.32

4.7

3.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

876

2251

2.39

109.87

1.1

iu/ml

1.3

2.2

1.13

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2467

9167

1.67

108.88

4.0

3.9

50.2

47.5

5.86

2445

9062

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2949

11494

1.59

107.68

7.8

9.9

mmol/l

24.4

24.3

1.12

2713

10777

(3007930) Methemoglobin/Hemoglobin.total in Blood

2257

8213

1.70

107.61

5.0

5.1

0.9

2.92

2106

7724

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2296

8397

1.69

107.48

4.9

5.0

1.7

2.23

2146

7902

(3017732) Neutrophils [#/volume] in Blood

3608

14787

1.52

105.58

3.0

2.9

e9/l

4.1

0.46

2764

11416

(3020779) Urea [Moles/volume] in Serum or Plasma

4546

19550

1.45

104.98

6.9

7.6

mmol/l

10.1

0.09

4301

18574

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1531

5007

1.88

103.89

1.3

u/ml

5.4

7.9

1.02

233

805

(3017143) Hepatitis C virus Ab [Presence] in Serum

5252

23312

1.41

101.96

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1450

4692

1.90

101.56

1.3

mg/l

619.8

554.1

1.09

1386

4472

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1505

4951

1.87

100.29

1.3

u/ml

3.3

5.5

0.94

144

524

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1319

4150

1.96

100.23

1.4

e6/l

32.1

35.4

0.15

1064

3127

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1319

4151

1.96

100.17

1.4

1.5

e6/l

1725.7

2084.4

0.18

1121

3292

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2516

9608

1.62

99.64

1.6

1.7

g/l

1.6

1.5

1.49

2159

8175

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1588

5328

1.84

99.53

2.6

2.1

g/l

0.0

0.46

1450

4821

(3039000) Anion gap in Blood

1353

4307

1.93

99.42

6.1

7.2

mmol/l

10.9

11.3

4.40

1219

3885

(3018572) Chloride [Moles/volume] in Blood

1353

4308

1.93

99.35

6.1

7.2

mmol/l

105.0

105.2

0.42

1219

3886

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1295

4064

1.96

99.13

1.2

u/ml

4.6

11.8

0.78

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4691

20506

1.43

98.93

2.2

2.3

g/l

0.2

1.24

4327

19094

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1566

5264

1.83

97.56

2.6

2.1

g/l

0.0

0.00

1443

4812

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1264

3968

1.96

96.65

1.2

titre

95.8

108.6

0.14

(3023420) DNA double strand Ab [Units/volume] in Serum

808

2122

2.33

96.63

1.4

1.5

iu/ml

27.7

38.7

1.24

(3027273) Bicarbonate [Moles/volume] in Venous blood

2583

10052

1.59

94.57

3.4

mmol/l

25.3

25.2

1.85

2502

9767

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1281

4101

1.92

92.55

1.3

1.2

u/ml

4.6

6.5

0.50

308

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2508

22916

0.65

91.13

1.8

—

(3019225) pH of Specimen

4749

21112

1.41

90.65

4.6

4.1

—

(3022313) Gas panel - Capillary blood

2397

9284

1.60

89.38

4.0

3.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1273

4134

1.89

88.14

1.3

mmol/l

3.8

0.15

1189

3883

(3026470) Cobalt [Mass/volume] in Blood

504

1095

2.81

87.89

2.1

1.9

ug/l

3.9

3.6

0.27

440

973

(3020961) Endomysium IgA Ab [Titer] in Serum

2356

9136

1.60

87.38

1.1

titre

131.6

235.8

1.04

253

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2105

7954

1.63

86.67

4.2

3.7

mmol/l

25.0

24.8

1.32

1936

7333

(3025577) Chromium [Mass/volume] in Blood

493

1067

2.82

86.57

2.1

2.0

ug/l

2.2

2.3

0.18

420

893

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1288

4235

1.87

85.87

1.4

—

(3049717) Cytology report of Urine Cyto stain

2126

8088

1.62

85.19

2.6

2.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1221

3964

1.89

84.60

1.3

1.2

u/ml

42.8

43.6

0.05

121

400

(3014051) Protein [Presence] in Urine by Test strip

1276

4244

1.85

82.09

2.3

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

321

549

3.57

81.77

2.6

au/ml

143.6

147.5

0.04

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

906

2679

2.07

81.50

6.7

6.0

mg/l

11.9

11.4

2.43

837

2450

(3034891) Synovial lining cells/100 cells in Synovial fluid

442

936

2.88

80.67

1.5

3.9

3.5

0.20

226

(3024263) Appearance of Synovial fluid

446

958

2.84

79.41

1.8

1.6

—

(3010421) pH of Blood

1582

5680

1.71

78.81

3.9

7.4

0.33

1343

4818

(21494890) Protein electrophoresis panel - 24 hour Urine

720

1970

2.24

78.47

2.1

2.0

—

(3000492) Spirometry study

4629

21037

1.37

76.66

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

333

611

3.33

76.63

2.8

3.2

mg/l

6.9

8.2

2.54

263

494

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3085

13049

1.47

76.46

3.1

3.4

pmol/l

4.4

4.5

3.14

2721

11682

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2002

7711

1.60

76.16

1.1

u/ml

13.0

5.2

0.42

116

(3045424) Erythrocytes [Presence] in Urine

1060

3415

1.90

75.13

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2457

9989

1.52

73.77

4.2

4.3

mmol/l

24.2

24.1

1.05

2142

9063

(40767503) Oxygen content in Capillary blood by calculation

1312

4562

1.77

73.03

2.6

2.5

16.2

16.4

0.67

693

2333

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

901

2787

1.98

71.80

1.3

nmol/l

0.6

1.7

1.20

860

2692

(40768443) Skin Pathology biopsy report

2349

9512

1.53

71.79

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

900

2786

1.98

71.57

1.3

nmol/l

0.2

0.3

0.14

185

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1586

15238

0.62

71.57

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1453

5255

1.70

70.45

2.8

3.0

mmol/l

24.9

24.7

0.94

1288

4606

(3044927) Protein electrophoresis panel - Urine

659

1827

2.21

69.66

1.2

—

(36660697) Celiac disease serology panel - Serum

3600

15930

1.40

69.59

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

989

3207

1.89

68.76

1.5

1.6

g/l

0.7

0.8

4.45

715

2393

(3026389) Candida sp identified in Specimen by Organism specific culture

871

2704

1.97

68.71

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7133

34974

1.28

68.70

1.5

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2683

11270

1.47

68.66

2.8

2.7

e6/l

0.3

0.20

2616

10957

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2183

8795

1.53

68.22

2.1

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1714

6530

1.62

68.08

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

1670

6323

1.63

68.00

3.4

3.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2388

9847

1.50

66.90

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

1375

4968

1.70

66.89

4.0

kpa

8.5

8.6

0.41

1349

4841

(3012501) Base excess in Blood by calculation

1368

4940

1.70

66.68

3.9

mmol/l

2.4

2.6

0.83

989

3338

(3013290) Carbon dioxide [Partial pressure] in Blood

1368

4942

1.70

66.59

3.9

kpa

5.0

2.62

1342

4815

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

823

2539

1.99

66.09

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2002

7994

1.54

65.10

2.0

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

411

946

2.65

64.59

1.2

1.1

iu/ml

3.4

4.4

0.68

(4062490)

676

1961

2.11

63.94

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

790

2434

1.99

63.68

1.3

1.2

u/ml

40.0

59.9

1.29

146

(1616796) Gas panel - Central venous blood

1340

4876

1.69

63.51

3.5

3.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

281

524

3.27

63.20

1.3

1.4

50.3

56.6

1.66

238

452

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1314

4765

1.69

63.07

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3392

15102

1.39

63.00

1.3

1.5

—

(3023419) Bacteria identified in Sputum by Culture

791

2448

1.98

62.97

2.2

2.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1281

4620

1.70

62.72

2.8

2.9

kpa

8.0

8.1

1.73

1199

4270

(3017315) Amylase [Enzymatic activity/volume] in Urine

395

907

2.66

62.37

1.3

1.2

u/l

194.3

407.0

3.21

369

845

(3028271) Lactate [Moles/volume] in Capillary blood

998

3352

1.83

62.24

2.0

1.8

mmol/l

1.7

1.8

1.85

976

3269

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1336

4886

1.68

62.14

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

672

1970

2.09

61.89

1.4

g/l

0.4

1.37

466

1322

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

421

1004

2.56

61.78

1.1

nmol/l

2.6

7.3

1.51

215

(3028192) IgG subclass 2 [Mass/volume] in Serum

672

1972

2.08

61.73

1.4

g/l

2.8

3.0

2.39

463

1327

(3027135) IgG subclass 1 [Mass/volume] in Serum

672

1973

2.08

61.65

1.4

g/l

6.4

7.0

4.41

462

1326

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1041

3560

1.79

61.24

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

922

3039

1.86

61.00

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1293

4711

1.69

60.99

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1495

5668

1.62

60.50

1.9

2.1

mg/l

10.7

11.0

0.82

1387

5294

(3044290) Cell count panel - Cerebral spinal fluid

1134

4000

1.74

60.08

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3708

16881

1.36

59.95

2.4

2.1

nmol/l

12.5

12.7

0.52

3226

15107

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4884

23185

1.31

59.42

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8737

44576

1.23

58.43

3.0

2.9

ug/l

0.7

0.8

11.82

6010

28599

(3021901) Oxygen saturation in Capillary blood

1099

3895

1.73

57.27

2.7

2.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1515

5895

1.58

55.06

1.4

1.5

iu/ml

11.1

14.4

0.63

143

(40757494) Bilirubin.total [Moles/volume] in Blood

395

980

2.46

53.58

2.2

2.1

umol/l

34.7

24.5

0.35

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

687

2144

1.96

53.48

1.4

1.3

nmol/l

38.0

24.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

952

3303

1.77

53.40

1.3

—

(3003181) Sodium [Moles/volume] in Urine

980

3442

1.74

52.72

1.4

mmol/l

60.4

62.3

0.71

786

2687

(3022806) Fractional oxyhemoglobin in Capillary blood

809

2692

1.84

52.01

1.9

1.8

89.7

89.4

0.66

797

2655

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

275

573

2.93

51.82

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25234

142271

1.16

51.73

2.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5495

26939

1.27

51.59

1.9

1.7

1.6

1.4

23.82

4719

23812

(3004616) Nuclear Ab [Presence] in Serum

743

2422

1.88

50.92

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

837

2843

1.80

50.39

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

798

2687

1.82

49.43

1.3

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

794

2695

1.80

47.94

2.1

2.2

32.7

0.04

786

2677

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1182

4494

1.61

47.28

1.4

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1263

4881

1.59

47.23

2.3

2.2

g/l

129.1

130.4

0.89

956

3500

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1181

4493

1.61

47.12

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

424

1156

2.24

46.80

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1490

5994

1.53

46.72

1.2

titre

131.7

124.5

0.10

127

529

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

224

440

3.10

46.60

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1848

7781

1.46

46.41

1.6

—

(3042631) Mycobacterium sp identified in Specimen

834

2912

1.75

45.83

2.6

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

419

1150

2.22

45.55

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5686

28379

1.25

45.30

1.5

1.6

—

(3011985) Renin [Units/volume] in Plasma

807

2811

1.76

44.72

1.4

1.5

mu/l

59.8

65.0

0.37

716

2510

(3000330) Specific gravity of Urine by Test strip

2382

10571

1.39

44.68

3.7

3.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

461

1328

2.12

44.54

1.1

mg/l

299.7

279.4

0.65

400

1157

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

975

3588

1.66

44.34

1.7

—

(3003338) MCHC [Mass/volume]

33896

196355

1.16

44.29

25.2

16.4

g/l

331.9

332.5

22.56

33676

194639

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1055

3964

1.63

44.26

3.0

3.3

—

(3034770) Mitochondria Ab [Titer] in Serum

1458

5909

1.51

44.16

1.2

titre

1037.6

934.9

0.19

183

(3020876) Protein [Mass/time] in 24 hour Urine

556

1732

1.96

43.60

1.9

2.0

g/24h

1.2

0.04

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

471

1383

2.08

43.36

1.2

1.1

mg/l

42.4

45.8

0.59

390

1138

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

353

924

2.33

42.81

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2274

10114

1.38

42.05

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

753

2621

1.76

41.86

1.3

1.4

pmol/l

259.3

298.1

1.58

596

2017

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1741

7392

1.45

41.83

2.9

3.0

u/ml

0.3

0.18

988

4154

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

722

2483

1.78

41.80

2.2

2.0

mg/l

26.5

27.7

0.20

177

677

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1292

5178

1.53

41.22

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

596

1940

1.88

41.12

1.1

au/ml

27.7

26.2

—

(3017704) Immunofixation for Urine

371

1015

2.23

40.70

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

573

6163

0.56

40.13

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

245

554

2.69

40.04

1.3

1.2

g/l

41.2

39.5

0.87

133

303

(3017817) Protein [Mass] in Urine collected for unspecified duration

564

1819

1.89

40.02

2.4

2.3

0.3

0.9

—

(1761868) Lipid panel - Serum or Plasma

13037

87899

0.86

39.60

3.1

2.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

579

1894

1.87

39.37

1.1

au/ml

35.5

86.8

—

(3037121) Protein [Mass/volume] in Urine

1711

7325

1.43

39.32

3.0

3.3

g/l

0.3

0.13

709

3321

(3023183) Ammonium ion [Moles/volume] in Plasma

1143

4513

1.55

39.00

2.4

2.8

umol/l

33.2

34.6

0.86

938

3844

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

293

736

2.43

38.90

1.9

1.7

umol/l

122.3

119.0

0.05

151

362

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

433

1287

2.05

38.67

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

260

621

2.55

38.28

2.1

1.9

ug/l

62.4

58.5

0.32

253

608

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

213

458

2.83

38.17

1.4

1.3

34.0

38.8

0.87

133

323

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

259

3531

0.44

37.67

1.5

—

(44813793)

437

1317

2.02

37.63

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

774

2799

1.69

37.63

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

580

1928

1.84

37.55

2.9

2.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1303

5365

1.49

36.60

2.4

ug/min

108.1

113.4

0.16

743

3227

(4027681)

367

1046

2.14

36.53

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1129

4513

1.53

36.47

2.0

1.8

pmol/l

198.6

202.2

0.53

1054

4293

(3043238) Trisomy 21 risk [Likelihood] in Fetus

186

2848

0.39

36.18

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

894

3396

1.61

35.96

1.5

1.6

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

6.53

35.81

1.3

mg/l

1.8

1.6

0.52

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

246

3321

0.45

34.89

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

248

3337

0.45

34.86

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

248

3333

0.45

34.75

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

246

3311

0.45

34.61

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

524

1732

1.85

34.58

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

524

1732

1.85

34.58

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

524

1732

1.85

34.58

1.6

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

185

2782

0.40

34.50

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

518

1708

1.85

34.44

1.1

—

(3005033) Fetal Nuchal fold Thickness US

185

2767

0.40

34.06

1.4

—

(44806118)

623

2183

1.74

33.95

1.5

—

(44790049)

623

2184

1.74

33.89

1.5

—

(44790047)

623

2185

1.74

33.84

1.5

—

(44790048)

623

2185

1.74

33.84

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

555

1883

1.80

33.71

1.6

—

(3008295) Osmolality of Serum or Plasma

573

1968

1.78

33.43

1.4

mosm/kgh2o

278.0

279.7

0.80

422

1570

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

578

2005

1.76

32.62

3.6

3.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

690

2517

1.67

32.55

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

474

1549

1.87

32.44

1.2

u/ml

93.6

67.7

0.74

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1335

5665

1.44

32.18

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

474

1554

1.86

32.12

1.2

u/ml

44.7

46.6

0.05

119

(3038026) Centromere Ab [Units/volume] in Serum

482

1592

1.85

31.93

1.2

u/ml

104.0

41.9

1.98

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2893

13872

1.28

31.76

1.2

iu/ml

122.1

152.4

4.01

1114

5257

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4665

23632

1.22

31.52

3.2

4.3

ug/l

28.1

26.7

0.06

3812

19029

(46235355) HIV 1 and 2 tests - Meaningful Use set

6462

33753

1.19

31.49

1.6

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1466

6361

1.41

31.29

1.8

1.7

nmol/l

41.2

0.01

1422

6200

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

443

1436

1.88

31.10

1.5

u/ml

22.9

26.1

0.55

302

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

453

1487

1.86

30.61

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

885

3486

1.55

30.60

3.2

3.3

1.3

1.5

0.78

681

2720

(3009542) Hematocrit [Volume Fraction] of Blood

36215

212488

1.14

30.55

20.1

14.0

39.4

39.9

20.62

23843

157113

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1488

1.85

30.28

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

450

1481

1.85

30.17

1.2

u/ml

3.2

8.0

1.07

102

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

454

1499

1.85

30.14

1.4

1.3

mmol/l

2.1

2.2

0.62

420

1396

(40759836) Histone Ab [Presence] in Serum by Immunoblot

451

1486

1.85

30.13

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

324

950

2.08

30.13

1.1

u/l

1.1

0.36

145

442

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

453

1496

1.85

30.06

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1493

1.85

29.97

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1494

1.85

29.91

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1526

12562

0.73

29.86

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1671

0.29

29.51

20.1

17.8

nmol/l

1540.4

3375.1

0.93

1600

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1147

4814

1.46

29.32

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

876

3478

1.54

29.26

1.1

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

636

2338

1.66

29.20

1.2

u/l

55.5

63.6

2.26

446

1554

(3004451) EKG impression Narrative

325

968

2.05

29.03

1.4

1.2

—

(4094501)

1377

6002

1.40

28.65

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

586

2120

1.69

28.58

1.6

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1591

0.29

28.48

14.6

12.5

nmol/l

874.1

1470.9

0.47

1539

(3024928) Oxygen saturation in Venous blood

1055

4418

1.46

27.30

3.0

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1019

4245

1.47

27.09

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

435

1470

1.80

26.89

1.7

2.1

nmol/l

16.9

17.6

0.88

409

1387

(3027456) Digoxin [Moles/volume] in Serum or Plasma

968

4004

1.48

26.68

3.2

3.1

nmol/l

0.8

0.12

728

3104

(3016018) Differential panel - Cerebral spinal fluid

589

2176

1.65

26.59

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

375

4041

0.56

26.56

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

522

1876

1.70

26.13

1.4

1.3

nmol/l

1.6

1.4

2.52

483

1681

(3036071) Salmonella sp Ab [Titer] in Serum

218

578

2.30

25.94

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

461

1604

1.75

25.88

1.9

1.8

mg/l

3.9

3.8

0.23

440

1523

(3040151) Glucose [Moles/volume] in Capillary blood

629

2388

1.61

25.51

4.9

7.2

mmol/l

7.2

7.5

1.29

514

1954

(3003694) ABO and Rh group [Type] in Blood

11075

61031

1.13

25.45

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

526

1910

1.68

25.37

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

316

981

1.96

25.29

3.4

3.8

—

(3014271) Vancomycin [Susceptibility]

329

1036

1.93

25.28

3.3

2.8

—

(4024509)

511

1845

1.69

25.18

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

676

2626

1.57

24.93

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

537

1971

1.66

24.89

1.7

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

385

1285

1.83

24.82

1.2

u/l

94.0

93.1

0.05

335

1126

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1418

6364

1.36

24.78

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

100

177

3.44

24.64

1.3

1.2

mmol/l

5.8

6.8

0.61

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

674

2625

1.57

24.59

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

674

2626

1.57

24.55

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

375

1249

1.83

24.34

1.2

u/l

29.2

24.8

0.65

320

1076

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

693

2729

1.55

24.10

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1051

4513

1.42

23.85

2.8

3.5

u/ml

314.0

853.8

2.66

936

4098

(3024522) Salmonella sp identified in Specimen by Organism specific culture

678

2672

1.55

23.51

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

381

1291

1.80

23.43

1.4

—

(3023410) Appearance of Cerebral spinal fluid

538

2008

1.63

23.41

1.5

1.6

—

(3045716) Anion gap in Serum or Plasma

282

865

1.99

23.38

2.6

2.2

mmol/l

8.9

9.3

0.77

201

648

(3047189) Immunofixation for 24 hour Urine

285

880

1.97

23.21

1.7

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

687

2724

1.54

23.19

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

675

2666

1.55

23.19

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

386

1320

1.78

23.04

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

546

2054

1.62

23.04

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

378

1288

1.79

22.84

1.2

mmol/l

33.2

35.1

0.85

318

1115

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

720

2896

1.52

22.78

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

275

847

1.98

22.57

1.6

nmol/l

3.4

6.5

0.54

230

721

(3019420) Tryptase [Mass/volume] in Serum or Plasma

302

964

1.91

22.38

1.5

ug/l

10.7

7.8

0.84

276

865

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

820

3402

1.47

22.34

1.4

1.3

u/l

36.4

32.7

0.27

729

2939

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

408

1434

1.73

22.21

1.3

u/ml

0.8

1.4

0.92

184

646

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

366

1246

1.79

22.20

1.4

1.3

titre

515.0

398.9

0.21

(44816559) Phosphatidylethanol [Mass/volume] in Blood

889

3763

1.44

21.85

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

289

919

1.92

21.67

1.2

1.3

58.5

56.8

0.09

106

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

179

472

2.31

21.67

1.2

1.3

nmol/l

139.8

124.2

0.51

145

319

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

267

829

1.96

21.46

2.0

2.5

ug/l

21.1

235.2

1.04

253

785

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

166

426

2.37

21.34

1.5

ug/l

0.4

0.20

113

270

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1234

5556

1.36

21.18

1.1

u/ml

3.6

6.2

2.05

103

774

(3033923) Metanephrine [Moles/time] in 24 hour Urine

148

361

2.49

21.16

1.1

umol/24h

0.6

0.7

1.20

187

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

532

2033

1.60

21.11

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

454

1667

1.66

21.11

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

203

572

2.16

21.06

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

192

531

2.20

20.84

1.6

ug/l

9.4

9.0

0.60

192

531

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

273

866

1.92

20.65

2.4

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1220

5514

1.35

20.45

1.4

u/l

11.1

10.7

0.48

997

4492

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

242

739

1.99

20.40

1.1

ng/l

1027.4

486.7

0.57

193

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

351

1212

1.76

20.36

1.3

titre

88.9

88.0

0.01

102

(3008757) Leukocyte morphology finding [Identifier] in Blood

588

2322

1.54

20.29

3.6

3.7

—

(3002256) Pathology report gross observation

5651

30190

1.15

20.02

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

278

898

1.88

19.95

1.6

1.4

umol/l

22.0

27.3

2.07

263

850

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

213

626

2.07

19.90

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

538

2093

1.57

19.84

3.3

60.2

58.6

0.79

348

1348

(3000012) Reticulocyte production index

336

1157

1.77

19.69

1.5

—

(40762814) Titanium [Mass/volume] in Blood

130

309

2.56

19.62

2.3

ug/l

4.3

3.8

0.22

101

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

220

659

2.03

19.56

1.3

1.4

pmol/l

15.4

15.1

0.26

172

563

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

596

2390

1.52

19.21

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

116

3.67

19.02

1.0

—

(3012565) Volume of 24 hour Urine

323

1112

1.77

18.97

2.1

2.3

2029.1

1966.2

0.46

291

990

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1367

6370

1.31

18.63

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1002

4459

1.37

18.57

4.8

6.0

iu/ml

1883.4

1167.8

0.25

120

700

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1394

6520

1.31

18.49

2.3

2.5

g/l

3.7

3.6

0.27

1322

6223

(3024869) Neuronal Ab [Presence] in Serum

132

327

2.46

18.36

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

725

3060

1.45

18.18

1.1

au/ml

11.2

12.3

0.18

195

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

410

1535

1.63

17.78

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

431

1641

1.60

17.47

1.5

1.4

promille

1.5

1.3

1.02

312

1304

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

281

2916

0.58

17.47

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

213

661

1.96

17.26

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

143

380

2.29

17.13

1.2

mg/l

29.1

45.4

0.19

113

282

(3011412) CD3 cells [#/volume] in Blood

505

2006

1.53

17.07

2.1

2.4

e9/l

1.2

1.1

1.10

312

1205

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

212

661

1.95

16.97

1.2

g/l

0.3

0.16

164

523

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

330

1185

1.70

16.80

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

166

475

2.13

16.70

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

166

475

2.13

16.70

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

166

475

2.13

16.70

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

166

475

2.13

16.70

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

196

599

1.99

16.60

1.2

21.6

24.9

0.20

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

328

1180

1.69

16.59

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

372

1384

1.64

16.57

1.6

1.5

u/l

6.6

6.0

0.26

197

654

(3036489) Thrombin time

1693

8231

1.26

16.57

2.0

21.3

21.6

0.75

1467

7231

(3000034) Microalbumin [Mass/volume] in Urine

485

1923

1.54

16.55

2.9

3.0

mg/l

29.8

53.2

1.99

349

1377

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

240

788

1.85

16.50

2.7

2.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

237

775

1.86

16.50

1.6

umol/l

29.4

29.6

0.09

225

742

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

388

1461

1.62

16.49

1.7

1.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.39

16.47

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

1042

1.74

16.43

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

7.66

16.41

1.7

1.6

nmol/l

251.0

256.1

0.01

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

357

1320

1.65

16.30

1.0

ng/l

35.6

43.3

3.70

221

966

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

136

362

2.28

16.26

1.4

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

356

1318

1.64

16.18

1.0

ng/l

782.0

724.5

1.31

218

940

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

354

1309

1.65

16.17

1.0

ng/l

278.6

362.9

2.22

221

970

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

100

1405

0.43

16.08

1.3

1.2

—

(4015189)

177

530

2.03

15.87

2.8

2.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

198

619

1.95

15.77

1.2

110.9

112.6

0.37

176

550

(3016650) Hepatitis A virus Ab [Presence] in Serum

798

3528

1.38

15.48

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1101

5120

1.31

15.30

1.7

1.8

iu/l

28.8

7.9

0.82

376

1893

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.46

15.28

1.0

u/ml

0.1

0.13

(3047007) Chlamydophila sp Ab [Presence] in Serum

675

2912

1.41

15.12

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

1046

1.70

15.06

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

334

1244

1.63

14.88

1.1

iu/ml

9.5

8.4

0.29

330

(3051611) Lipemic interference index of Serum or Plasma

550

2293

1.46

14.81

3.6

3.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

686

2982

1.40

14.73

1.1

g/l

1.5

0.26

615

2706

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

792

3540

1.36

14.40

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

343

1299

1.61

14.32

1.8

1.7

—

(3006270) Folate [Moles/volume] in Blood

454

1834

1.51

14.30

1.2

nmol/l

341.8

370.2

2.09

378

1523

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

381

1486

1.56

14.07

1.7

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

272

975

1.70

14.04

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

212

706

1.83

14.03

1.2

g/l

0.7

0.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

354

1358

1.59

14.03

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

361

1394

1.58

13.92

2.2

2.5

e6/l

505.4

545.5

0.54

304

1160

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

826

3741

1.35

13.82

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5082

27623

1.13

13.63

5.0

4.3

32.4

32.1

1.03

3573

18916

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.96

13.63

1.0

u/ml

0.2

0.1

0.42

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

356

1378

1.57

13.61

2.3

3.7

nmol/l

111.0

141.5

1.01

351

1357

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

277

1010

1.67

13.45

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

277

1010

1.67

13.45

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1172

5597

1.28

13.38

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

238

835

1.73

13.29

1.1

1.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

399

1595

1.52

13.24

1.8

1.9

73.3

72.2

0.74

374

1534

(3018851) Theophylline [Moles/volume] in Serum or Plasma

149

2.86

13.11

1.8

1.7

umol/l

51.5

46.1

0.51

149

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

531

2253

1.44

13.11

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

160

2.77

13.00

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

344

1341

1.56

12.79

2.2

2.6

e9/l

0.2

0.02

301

1153

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

478

1.96

12.64

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

116

3.09

12.62

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

152

470

1.97

12.61

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

145

442

2.00

12.51

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

272

2614

0.63

12.46

1.7

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

226

797

1.73

12.43

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

389

1572

1.51

12.31

1.8

1.9

15.3

14.7

0.30

184

675

(3002619) Bacteria identified in Specimen by Culture

130

383

2.06

12.30

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

543

1.88

12.27

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

222

782

1.73

12.27

1.6

1.7

umol/l

2.2

2.0

2.56

209

734

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

362

1444

1.53

12.18

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

568

2474

1.40

12.16

1.1

—

(3017569) Oxygen content in Arterial blood

254

939

1.65

11.78

2.4

2.1

—

(3003129) Base excess in Capillary blood by calculation

156

499

1.90

11.78

1.8

1.6

mmol/l

0.8

0.5

0.25

147

470

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

208

729

1.74

11.73

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

458

1.94

11.67

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1237

6047

1.25

11.66

2.9

3.1

mg/l

1.6

1.5

2.49

1117

5561

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

280

1072

1.59

11.31

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

393

1625

1.47

11.18

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

233

856

1.66

11.10

1.1

miu/ml

1515.1

1530.1

0.07

233

856

(3001186) Copper [Moles/volume] in Serum or Plasma

143

454

1.92

11.07

1.3

1.2

umol/l

16.8

17.2

0.40

126

400

(3032057) Clostridioides difficile [Presence] in Stool

132

409

1.96

10.96

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

212

2091

0.61

10.95

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

114

336

2.06

10.84

1.5

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

186

647

1.75

10.81

1.9

2.3

ug/l

1.0

1.1

0.08

171

613

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

307

1215

1.54

10.77

1.1

ratio

1.1

0.62

109

451

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

263

1005

1.59

10.74

2.2

2.1

ug/min

97.6

116.3

0.19

235

(3035320) C reactive protein [Mass/volume] in Body fluid

365

1505

1.48

10.57

3.1

2.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

267

1029

1.58

10.53

1.6

mmol/24h

7.0

5.3

0.97

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

189

1896

0.60

10.50

1.4

1.5

ug/l

3.4

4.0

0.24

133

1568

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

418

1774

1.43

10.43

1.2

titre

166.0

186.4

0.21

310

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

429

1830

1.43

10.41

1.1

1.3

titre

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

261

2.19

10.39

1.5

1.3

49.8

52.6

0.19

128

(3019977) pH of Arterial blood

293

1158

1.54

10.37

3.0

2.4

7.4

0.22

105

426

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

124

385

1.96

10.27

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

476

1.85

10.20

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

609

2764

1.34

10.20

1.8

1.9

ug/l

31.3

23.9

0.76

593

2708

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

127

399

1.94

10.18

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

180

633

1.73

10.11

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

143

469

1.85

10.09

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

133

2.70

10.08

1.0

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

415

1771

1.43

10.07

1.2

titre

346.3

163.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

1183

1.52

9.98

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

263

1024

1.56

9.96

10.1

10.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

280

1106

1.54

9.96

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

147

489

1.83

9.93

1.2

pmol/l

268.3

300.7

0.43

100

370

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

201

733

1.67

9.91

1.8

1.9

28.1

29.6

0.66

186

690

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

442

3702

0.72

9.91

1.7

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

202

738

1.66

9.89

1.7

1.9

9.3

10.7

1.00

183

680

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

852

0.43

9.89

1.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

280

1109

1.54

9.84

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

280

1109

1.54

9.84

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

280

1109

1.54

9.84

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

262

1026

1.55

9.70

2.8

3.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

288

1152

1.52

9.69

1.4

1.5

nmol/l

1.2

1.3

0.99

215

910

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

135

441

1.86

9.67

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

378

1600

1.44

9.61

1.1

mg/l

287.2

477.1

0.52

335

1441

(3016750) Collection duration of Urine

327

1348

1.48

9.54

2.2

min

496.9

499.7

0.20

236

1007

(21494434) Karyotype in Bone marrow

419

1815

1.41

9.39

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

170

602

1.72

9.36

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

168

2.42

9.34

1.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

733

3460

1.29

9.32

2.3

2.8

u/ml

1366.5

3120.9

0.53

195

(3044242) Glucose [Moles/volume] in Arterial blood

251

983

1.55

9.31

2.3

1.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

143

482

1.80

9.30

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

162

2.44

9.18

1.5

1.3

pmol/l

15.4

0.00

139

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

243

2.15

9.17

1.9

1.5

—

(3036603) Volume of Urine

357

1517

1.43

8.93

1.8

1.6

2036.9

1956.4

0.37

359

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.32

8.84

1.5

1.4

—

(3028433) Virus identified in Specimen by Culture

186

688

1.64

8.76

1.1

1.2

—

(4211845)

269

1087

1.51

8.69

4.0

2.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

363

1558

1.42

8.62

2.3

2.6

e6/l

739.7

706.2

0.15

143

615

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

236

929

1.55

8.60

1.1

u/ml

44.4

7.7

0.94

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

117

2.65

8.50

1.7

1.5

15.1

13.4

0.18

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

894

4377

1.24

8.45

1.3

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

168

611

1.67

8.45

1.1

95.6

84.1

3.29

291

(3028717) Thiamine [Mass/volume] in Blood

196

2.23

8.42

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

128

431

1.81

8.41

1.2

1.3

mu/l

68.0

70.0

0.04

329

(3028707) Methadone [Presence] in Urine by Screen method

586

2725

1.31

8.39

3.0

2.6

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

136

2.50

8.37

1.6

1.5

38.4

40.2

0.10

(4146454)

520

2381

1.33

8.31

2.7

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.33

8.28

1.0

1.1

mmol/l

5.4

5.5

0.07

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

539

2483

1.32

8.26

2.6

3.4

nmol/l

4.6

8.0

0.83

516

2420

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

299

1250

1.46

8.20

2.5

2.7

41.1

38.2

0.96

103

398

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

162

589

1.67

8.18

1.1

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

884

4348

1.24

8.04

1.3

1.5

u/ml

20.9

20.2

0.06

(3001686) Cold agglutinin [Titer] in Serum or Plasma

109

354

1.87

8.03

1.1

1.4

titre

113.4

213.1

—

(3010503) CD19 cells [#/volume] in Blood

308

1302

1.44

7.99

2.3

2.6

e9/l

0.3

0.4

0.67

294

1269

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

170

633

1.63

7.86

1.1

93.9

85.0

3.38

304

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

258

1058

1.48

7.82

1.3

mmol/l

6.0

5.8

1.36

237

993

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

287

1203

1.45

7.79

2.7

2.8

ug/l

29.5

24.7

—

(3005570) Glucose [Moles/volume] in Urine

475

2172

1.33

7.70

2.2

1.8

—

29.1

—

(3001729) Color of Synovial fluid

161

2.30

7.69

1.5

1.7

—

(3006462) Nitrate [Presence] in Urine

246

1004

1.49

7.65

4.1

3.0

—

(3020491) Glucose [Moles/volume] in Blood

359

1580

1.38

7.45

1.9

1.8

mmol/l

7.2

7.0

0.64

273

1087

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

299

1275

1.43

7.44

1.8

u/field

2.4

2.5

0.10

206

926

(3019832) Treponema pallidum Ab [Presence] in Serum

2218

15212

0.88

7.40

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

193

753

1.56

7.39

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1573

8232

1.17

7.36

2.8

3.7

u/ml

1236.4

1993.3

0.40

1315

7088

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

912

4551

1.22

7.28

1.8

1.9

nmol/l

0.9

0.8

0.82

767

3799

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

227

922

1.50

7.25

1.9

1.7

156.0

147.7

0.73

210

869

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

167

2.22

7.11

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

228

931

1.49

7.11

2.9

5.5

mg/l

72.0

2628.6

3.26

159

663

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

648

3125

1.26

7.07

1.4

1.3

u/l

30.3

31.2

0.30

522

2570

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

216

874

1.50

7.04

2.1

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1154

8269

0.84

7.01

1.8

1.7

mg/l

4.2

3.5

0.93

871

5801

(3013293) Extractable nuclear Ab [Presence] in Serum

305

1.87

7.01

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1337

6940

1.17

6.95

2.1

2.2

92.0

90.9

0.97

1244

6456

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

213

866

1.50

6.81

2.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

213

867

1.49

6.77

2.1

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

329

1452

1.38

6.77

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1170

6021

1.18

6.76

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

127

1251

0.62

6.74

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

673

3281

1.25

6.72

1.2

u/ml

3.6

0.02

224

1172

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

357

1599

1.36

6.71

1.5

1.4

u/l

12.4

12.8

0.59

339

1548

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

203

820

1.51

6.70

1.5

1.2

umol/l

2.9

4.4

8.87

179

754

(3042517) Benzodiazepines panel - Urine

148

2.26

6.70

3.6

2.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

349

1558

1.36

6.69

1.1

—

(3022689) Creatine [Moles/volume] in Urine

159

608

1.59

6.68

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

188

2.10

6.67

1.1

umol/24h

1.6

1.8

0.71

188

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

100

2.55

6.61

1.5

1.3

1.7

1.1

0.33

(3006442) Creatine [Moles/volume] in Serum or Plasma

347

1552

1.36

6.59

1.7

1.5

umol/l

71.0

71.2

0.02

113

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

288

1249

1.40

6.58

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

255

1082

1.43

6.58

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

329

1460

1.37

6.56

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

321

1.82

6.56

2.8

3.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

165

640

1.57

6.54

1.1

111.9

104.3

1.90

147

586

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

127

2.34

6.49

1.3

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

152

580

1.59

6.46

1.7

2.0

u/l

43.5

38.3

0.12

139

518

(3039443) Prostate specific Ag panel - Serum or Plasma

630

4741

0.80

6.44

1.5

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

281

1219

1.40

6.42

1.7

2.2

100.3

96.5

0.98

259

1153

(3000060) B lymphocytes [#/volume] in Blood

140

525

1.62

6.39

1.8

1.9

e6/l

236.0

1422.8

1.35

264

(3051339) Copper [Moles/volume] in Blood

2.76

6.38

1.2

1.1

umol/l

16.5

16.9

0.12

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

832

4173

1.21

6.38

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

217

899

1.47

6.36

2.4

3.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

136

2.28

6.36

1.6

1.8

0.5

0.8

0.87

108

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

117

2.39

6.35

1.1

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

264

1.89

6.31

1.6

ug/l

106.9

111.5

0.14

214

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

118

425

1.69

6.29

2.5

2.6

mmol/l

7.4

7.6

0.17

251

(3020650) Glucose [Presence] in Urine

150

575

1.59

6.27

1.5

1.4

—

(3027874) Urate [Moles/volume] in Urine

3.04

6.21

1.1

mmol/l

1.7

13.0

0.48

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1222

6361

1.17

6.19

2.4

192.5

192.2

0.03

1150

6038

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

800

4011

1.21

6.17

1.3

1.5

u/ml

110.4

112.8

0.23

199

874

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

216

1.97

6.09

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

399

1850

1.31

5.99

1.1

—

(3004775) Volume in Urine collected for unspecified duration

402

1867

1.31

5.97

2.4

2.2

683.8

689.2

0.09

281

1268

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

279

1.83

5.91

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

133

2.24

5.90

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

114

2.34

5.87

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

183

746

1.49

5.85

5.3

6.4

mmol/l

25.1

25.0

0.06

169

671

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

294

1.80

5.80

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

636

3137

1.23

5.79

2.2

2.7

u/ml

85.5

1121.2

2.07

626

3037

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1088

5645

1.17

5.77

1.3

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

104

2.40

5.73

1.4

1.6

umol/l

1.0

0.7

2.24

(3016244) Insulin [Units/volume] in Serum or Plasma

251

1097

1.39

5.57

3.0

3.4

mu/l

29.5

28.0

0.19

238

1028

(3011288) Drugs identified in Urine by Screen method

856

4366

1.19

5.56

3.2

2.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

106

385

1.67

5.53

2.6

2.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

776

3926

1.20

5.51

1.2

1.3

u/ml

285.4

275.9

0.41

475

2576

(3006969) Lambda light chains [Mass/volume] in Urine

3.34

5.46

1.1

g/l

0.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

260

1.82

5.46

1.5

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

142

557

1.55

5.45

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

112

415

1.64

5.43

1.3

—

(40757373) Influenza virus identified in Isolate

112

415

1.64

5.43

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

716

3601

1.21

5.42

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

268

1193

1.37

5.34

1.2

1.1

u/l

28.7

26.2

0.16

206

916

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

164

2.04

5.30

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

268

1195

1.36

5.29

1.2

1.1

u/l

86.2

88.1

0.10

212

953

(1617658) Protocol used for examination of sentinel lymph nodes

222

1863

0.72

5.29

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.77

5.26

1.2

3.2

mu/l

1.3

3.1

1.14

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

211

1.90

5.26

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

554

2723

1.24

5.25

1.5

e6/l

4476.7

2759.5

0.46

409

1962

(3042301) Urate [Moles/volume] in Synovial fluid

3.61

5.24

1.0

umol/l

395.8

331.8

0.74

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1400

7462

1.14

5.22

1.8

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

323

1.71

5.19

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

117

2.23

5.19

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

640

3201

1.22

5.15

1.2

u/ml

4.9

3.7

1.12

258

1454

(3003434) Protein [Mass/volume] in Pleural fluid

614

3059

1.22

5.13

1.5

1.4

g/l

32.6

33.1

0.40

558

2741

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

248

1.81

5.12

1.4

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

114

2.24

5.10

1.0

1.1

u/l

48.7

48.5

0.01

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

348

1.68

5.09

1.3

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

628

1.49

4.99

3.3

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

628

1.49

4.99

3.3

2.3

—

(40762365) Oxygen content in Arterial blood by calculation

102

378

1.64

4.98

2.6

3.2

ml/dl

15.1

14.6

1.05

354

(3005082) Progesterone [Moles/volume] in Serum or Plasma

708

0.57

4.85

1.3

nmol/l

36.3

30.9

0.40

636

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

531

3935

0.82

4.81

3.6

3.5

u/ml

38.6

37.9

0.04

521

3780

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

210

916

1.39

4.78

1.1

u/ml

8.5

7.4

0.14

161

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

543

2699

1.22

4.69

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

565

2820

1.22

4.68

1.3

mmol/l

7.4

7.3

0.12

424

2030

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

439

2133

1.25

4.67

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

178

1.91

4.59

1.2

ug/l

83.9

119.2

1.17

112

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

128

2.09

4.57

1.3

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

501

2477

1.23

4.57

1.4

1.5

e6/l

72605.0

54750.0

0.54

302

1477

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

112

435

1.56

4.56

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

166

702

1.44

4.52

1.7

1.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

137

2.04

4.51

1.5

mg/l

1.2

1.9

0.55

(3036180) Methadone [Presence] in Urine

4.05

4.48

4.0

2.8

—

(3008037) Lactate [Moles/volume] in Venous blood

945

4959

1.16

4.45

3.6

3.0

mmol/l

1.6

0.89

917

4870

(3013727) Leukocytes other/100 leukocytes in Blood

170

725

1.43

4.43

3.5

3.7

52.8

53.4

0.13

165

701

(3041918) Cholesterol [Moles/volume] in Pleural fluid

101

386

1.59

4.42

1.1

1.2

mmol/l

1.5

1.7

0.41

232

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

168

716

1.43

4.40

1.7

1.6

u/ml

121531.0

11270.4

0.70

(40765089) Chromosome analysis panel - Blood by G-banded

475

0.51

4.37

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

851

0.63

4.33

2.3

2.5

nmol/l

121.8

156.1

2.73

744

(3016228) CD19 cells/100 cells in Blood

200

882

1.38

4.32

1.9

2.0

7.9

8.8

0.50

191

862

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

180

780

1.40

4.31

3.1

2.9

umol/l

28.5

29.2

0.36

143

598

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

398

1934

1.25

4.27

1.9

2.0

u/field

1.7

2.3

1.56

179

821

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3003

19685

0.92

4.26

1.4

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.21

4.21

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

112

2.12

4.21

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

411

0.49

4.18

2.6

3.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

180

1.86

4.17

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

321

1.63

4.16

1.6

1.8

pmol/l

53.3

62.4

0.22

268

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

410

0.49

4.15

5.3

6.8

—

(3051651) Icteric interference index of Serum or Plasma

292

1373

1.29

4.11

3.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

1025

1.34

4.11

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

208

1.78

4.08

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

295

1.65

4.06

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.89

4.04

1.8

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

101

396

1.55

4.01

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

224

1.74

3.93

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

110

443

1.51

3.88

11.1

8.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

113

458

1.50

3.87

4.5

6.0

68.0

70.7

0.42

366

(3023383) Lactate [Moles/volume] in Pleural fluid

152

653

1.41

3.87

1.3

mmol/l

3.5

3.4

0.14

132

607

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

286

1.64

3.83

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

142

1.93

3.82

1.3

1.2

7.3

25.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

626

3222

1.18

3.82

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

150

645

1.41

3.80

2.8

3.3

—

(3048879) Bone marrow aspiration report

145

620

1.42

3.79

1.7

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

160

1.86

3.77

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

192

864

1.35

3.72

1.9

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

242

1.68

3.71

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

192

1.77

3.71

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

192

865

1.35

3.70

2.0

2.4

umol/l

57.6

53.8

0.83

150

721

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

195

883

1.34

3.64

1.1

103.3

98.0

1.72

152

701

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

132

1.93

3.63

1.3

pmol/l

14.7

18.3

0.64

111

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

107

2.04

3.61

1.1

u/l

3.1

3.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

258

1.65

3.61

1.3

1.4

nmol/l

0.2

0.3

0.80

179

(4198724)

176

787

1.36

3.57

1.9

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

886

4714

1.14

3.54

3.7

3.1

mmol/l

7.5

7.7

0.68

856

4643

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.14

3.49

1.0

1.1

u/ml

10.7

20.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.14

3.49

1.0

1.1

u/ml

47.9

21.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

122

514

1.44

3.49

10.8

8.2

—

(3000285) Sodium [Moles/volume] in Blood

261

1.63

3.47

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

420

2105

1.21

3.47

1.3

mmol/l

6.4

6.3

0.23

387

1946

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

475

1.46

3.46

1.1

—

(4306422)

616

3197

1.17

3.45

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

348

1.54

3.42

1.2

1.1

pmol/l

3.3

9.6

0.51

(36303858) Crystals [Presence] in Urine

3.43

3.41

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

106

437

1.47

3.40

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

174

784

1.35

3.39

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

115

486

1.44

3.27

1.1

u/ml

0.4

3.1

0.82

247

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.05

3.21

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.86

3.21

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

134

1.86

3.20

1.3

1.4

umol/24h

361.8

314.6

0.54

134

(4212803)

179

1.73

3.18

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

148

1.81

3.15

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

154

690

1.36

3.14

2.0

1.8

170.3

171.9

0.08

146

651

(3045788) Cell count panel - Pleural fluid

416

2107

1.20

3.12

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5720

33190

1.05

3.12

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

388

1954

1.21

3.10

2.0

2.1

41.8

39.4

0.43

236

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

1045

1.29

3.10

1.2

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

149

1.79

3.09

4.1

4.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1170

6392

1.11

3.09

1.6

1.7

mu/l

293.3

316.1

1.09

1066

5803

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.60

3.08

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

1046

1.28

3.08

1.2

1.5

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

3.0

2.4

0.21

101

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

2.2

2.1

0.02

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

0.6

1.5

1.12

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

2.1

1.8

0.13

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

0.7

0.9

0.35

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

1.7

2.0

0.16

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

1.3

1.9

0.64

100

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

3.2

3.4

0.09

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

136

1.83

3.08

1.5

mg/l

1.2

2.3

1.07

101

(3018133) Calcium [Moles/volume] in Urine

276

1.56

3.02

1.5

1.6

mmol/l

2.6

2.8

0.36

249

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.65

3.01

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

207

1605

0.78

3.00

1.3

g/l

1.6

1.5

0.36

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

133

1.83

2.99

1.1

u/field

1.1

1.2

0.68

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

111

475

1.42

2.98

2.2

2.6

—

(3035880) pH of Pleural fluid

250

1207

1.26

2.98

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2064

11606

1.08

2.97

2.8

3.6

u/ml

40.9

55.2

1.89

1993

11225

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

102

430

1.44

2.97

1.3

1.2

96.3

85.6

1.45

143

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

292

1.54

2.96

1.2

1.4

nmol/l

8.0

234447.1

1.67

241

(37019676) Renin [Units/volume] in Plasma --supine

2.54

2.96

1.1

1.0

mu/l

69.5

70.7

0.01

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

105

446

1.43

2.94

1.3

117.1

105.7

2.40

421

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

235

1.60

2.94

2.1

2.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.93

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

180

1.69

2.88

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.11

2.87

1.1

umol/24h

0.3

0.8

0.53

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

162

1.72

2.87

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

634

1.35

2.85

1.6

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

252

1.57

2.82

1.1

1.3

u/l

600.7

209.3

0.30

180

(3008116) Ketones [Moles/volume] in Urine by Test strip

410

1.44

2.81

1.7

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

296

1.52

2.81

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

145

1.76

2.80

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

327

1639

1.21

2.79

1.3

u/l

14.4

14.0

0.10

299

1519

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

244

0.47

2.76

6.4

7.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

101

433

1.42

2.72

1.2

71.0

77.8

0.59

139

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

348

1.47

2.71

1.8

2.1

umol/l

14.7

18.1

2.31

348

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2947

16850

1.07

2.71

1.7

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

195

926

1.28

2.70

1.6

1.5

iu/ml

3448522.6

2032895.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

388

1983

1.19

2.70

4.4

5.0

u/ml

166.8

87.2

0.78

107

628

(4281824)

365

2635

0.84

2.70

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

129

1.79

2.69

1.1

nmol/l

13.0

14.9

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

170

1.68

2.69

1.0

1.1

u/ml

5.4

3.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

1069

5862

1.11

2.69

4.7

3.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

401

2057

1.19

2.68

1.3

u/l

575.1

480.2

0.31

375

1954

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

216

0.45

2.67

1.3

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

133

600

1.35

2.66

1.4

27.7

20.5

1.79

123

536

(3012441) Differential panel - Pleural fluid

460

2390

1.17

2.64

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.90

2.64

8.7

9.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

355

1804

1.20

2.64

1.6

2.1

umol/l

7.8

9.0

0.43

250

1338

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.00

2.64

25.2

11.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

311

1.48

2.62

2.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

233

1.56

2.61

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

164

1281

0.78

2.59

12.5

12.6

mmol/l

0.6

0.19

154

1167

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

646

3456

1.14

2.50

1.1

iu/ml

16250.3

1342.3

0.45

138

703

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

265

1.51

2.50

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

457

0.64

2.47

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1509

9923

0.92

2.46

1.9

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

309

1563

1.20

2.45

1.4

umol/l

13.3

12.5

1.12

294

1485

(4133840)

137

630

1.32

2.44

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

365

0.60

2.42

2.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

168

797

1.28

2.39

1.4

59.2

62.8

0.60

142

651

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

122

554

1.34

2.38

1.4

1.5

mu/l

1385.8

742.8

0.37

117

525

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

583

3112

1.14

2.36

1.1

122.7

116.6

4.87

522

2815

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

178

1.60

2.31

2.1

2.2

—

(3041184) Isoniazid [Presence] in Urine

2.90

2.29

1.8

2.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

433

1.38

2.28

1.8

2.3

—

(3018291) Platelet Ab [Presence] in Serum

2.50

2.27

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

101

1.80

2.23

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.31

2.23

1.4

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

123

566

1.32

2.22

1.4

1.5

73.2

72.5

0.19

118

537

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

105

848

0.75

2.19

1.5

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

360

1.40

2.17

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

108

490

1.34

2.15

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

465

2465

1.15

2.13

1.3

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

6.07

2.12

1.4

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

122

959

0.77

2.10

1.6

1.5

mmol/l

8.7

7.8

2.52

572

(40768793) Breast Pathology biopsy report

775

5209

0.90

2.09

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.99

2.08

1.3

nmol/l

424.1

453.4

0.12

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.86

2.07

1.1

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.86

2.07

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

201

995

1.23

2.04

32.3

27.7

ug/l

113.2

115.2

0.18

176

816

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

146

1.62

2.04

1.1

u/l

10.2

10.4

0.03

146

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.77

1.99

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

456

2427

1.14

1.99

1.5

2.0

titre

2233.3

3677.6

0.48

132

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.89

1.98

1.0

1.1

pmol/l

154.7

241.8

0.92

(3019174) dRVVT (LA screen)

176

1.55

1.98

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

517

2776

1.13

1.98

2.6

2.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

286

1.42

1.95

2.2

2.7

u/field

0.4

0.5

0.51

286

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

338

1.38

1.92

6.3

7.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

277

1.43

1.91

3.0

3.1

umol/l

40.5

41.3

0.10

243

(36304079) Mucus [Presence] in Urine sediment

4.05

1.90

1.2

1.0

—

(40768441) Liver Pathology biopsy report

324

1690

1.17

1.89

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

483

2593

1.13

1.87

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

174

1.54

1.86

1.0

1.1

iu/ml

3.1

18.3

—

(4268621)

408

2170

1.14

1.83

2.3

—

(3025130) Human papilloma virus identified in Specimen

413

2853

0.88

1.83

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

250

1.43

1.81

1.2

u/ml

0.1

9.7

0.73

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

223

1134

1.20

1.77

3.8

6.7

u/ml

1684.4

3813.5

0.36

263

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

160

1191

0.82

1.77

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

152

1137

0.81

1.77

1.1

1.0

u/ml

0.4

1.0

0.52

136

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

340

1791

1.15

1.76

1.3

mmol/l

12.1

11.9

0.14

126

521

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.83

1.76

1.1

u/l

287.0

559.8

0.79

(3008402) Methanol [Moles/volume] in Serum or Plasma

237

1.44

1.74

1.1

1.2

mmol/l

—

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.95

1.72

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.81

1.69

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

130

1.59

1.68

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1650

10642

0.94

1.68

1.4

1.3

iu/l

31.2

31.8

0.31

1425

9244

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.89

1.68

1.1

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

195

986

1.20

1.67

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

139

680

1.24

1.64

1.4

3.8

2.5

0.92

117

570

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

131

1.58

1.64

1.6

1.3

u/l

1602.4

688.2

0.41

116

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.84

1.64

1.4

1.7

ug/l

138.4

103.4

0.24

(3044009) aPTT.lupus sensitive (LA screen)

180

1.48

1.63

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.75

1.61

1.6

1.5

u/l

0.3

0.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

509

3439

0.90

1.60

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

403

1.31

1.59

3.2

5.9

u/l

56.0

56.2

0.00

165

(3003740) Influenza virus B Ag [Presence] in Specimen

510

3444

0.90

1.59

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.81

1.57

4.9

5.9

mg/l

1.3

1.2

0.08

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.83

1.54

1.1

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

123

599

1.25

1.54

1.8

1.9

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.60

1.53

1.6

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

239

1.40

1.52

2.5

2.4

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.70

1.49

1.2

1.5

2.0

2.3

0.34

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.48

1.48

1.2

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

200

1.43

1.46

1.6

1.3

mg/24h

26.2

313.7

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.66

1.46

1.1

—

(40768806) Pleura Pathology biopsy report

450

2453

1.12

1.43

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

361

1944

1.13

1.42

1.5

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.15

1.36

1.0

1.1

titre

1727.3

2131.0

0.28

(3045683) HLA typing for celiac disease panel - Blood or Tissue

233

1222

1.16

1.36

1.0

—

(3024932) HLA-DR beta [Type]

109

816

0.81

1.35

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

199

1.40

1.33

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

129

1.51

1.32

6.3

5.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.43

1.30

1.1

—

(3027944) Amphetamines [Presence] in Urine

1077

6971

0.94

1.30

2.3

1.8

—

(3007463) Buprenorphine [Presence] in Urine

1.86

1.30

5.3

—

(40768795) Lymph node Pathology biopsy report

359

2437

0.89

1.29

1.1

1.2

—

(1002224) Polysomnography panel

1714

9898

1.05

1.28

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

2.60

1.28

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.17

1.26

1.0

u/ml

0.2

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

413

1.26

1.5

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.61

1.24

1.1

1.2

ng/l

2082.8

4729.2

1.01

(3015350) Toxocara sp Ab [Presence] in Serum

2.21

1.20

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

540

3005

1.09

1.20

1.1

u/ml

1.6

3.1

6.17

173

1535

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

214

1129

1.15

1.19

2.1

2.4

u/l

213.0

206.7

0.51

214

1121

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.76

1.19

1.0

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

2.76

1.19

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.02

1.19

1.1

1.4

2.9

2.38

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

428

2358

1.10

1.18

1.1

97.5

96.6

0.28

395

2205

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3218

18889

1.04

1.17

1.8

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

397

1.25

1.15

2.6

mg/l

53.9

51.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.11

1.15

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

119

1.48

1.13

1.2

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.96

1.12

1.0

—

54.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.96

1.12

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

1.34

1.11

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.55

1.11

1.1

1.0

u/ml

0.5

0.04

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

1.42

1.10

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

281

1.30

1.10

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

276

1.30

1.09

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

239

1.32

1.09

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

123

626

1.19

1.09

1.4

1.3

ug/l

116.5

310.1

1.28

339

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.24

1.08

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

107

538

1.21

1.08

1.5

1.4

23.0

21.5

0.21

449

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

411

0.77

1.08

3.8

5.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

352

1.26

1.08

5.2

5.1

ug/min

44.6

47.2

0.13

288

(3007700) Barley IgE Ab [Units/volume] in Serum

1.57

1.08

1.0

u/ml

0.1

0.7

0.84

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.87

1.07

1.3

1.2

—

(3024471) HLA-A [Type]

116

839

0.84

1.07

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

310

1.27

1.05

1.2

mmol/l

0.8

1.2

0.40

191

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.56

1.03

1.0

u/ml

0.1

0.3

0.77

(3003888) Timothy IgE Ab [Units/volume] in Serum

611

3450

1.08

1.00

1.1

u/ml

3.8

4.8

0.76

283

1679

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

169

1.37

1.00

5.2

4.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.69

0.99

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.50

0.98

1.0

u/ml

0.2

0.4

0.46

(3024316) Viscosity of Plasma

1.50

0.98

2.0

1.6

mpas

1.9

1.7

0.32

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.65

0.98

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.75

0.98

1.0

1.3

e6/l

32.5

38.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

534

1.19

0.97

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

914

5239

1.06

0.97

2.5

1.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.49

0.94

1.0

u/ml

0.0

1.5

0.85

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

120

0.61

0.91

1.3

1.8

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.14

0.90

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.94

0.90

1.0

1.1

mmol/24h

141.6

147.8

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.54

0.87

1.0

u/ml

0.1

0.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

255

1397

1.11

0.86

6.1

6.6

—

(3027008) Opiates [Presence] in Urine

1111

7075

0.95

0.85

2.4

1.8

—

(3028300) Cannabinoids [Presence] in Urine

1113

7087

0.95

0.85

2.5

1.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

147

0.66

0.85

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

342

1.23

0.85

1.5

1.4

10.6

12.4

0.23

174

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.44

0.83

1.0

1.2

g/l

0.1

0.21

(3002331) Protein [Mass/volume] in Peritoneal fluid

100

516

1.18

0.82

1.5

1.3

g/l

83.4

25.8

0.50

401

(3014891) Appearance of Pleural fluid

333

1.22

0.81

1.4

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

208

1.28

0.81

1.9

2.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

235

1.27

0.81

3.7

2.9

mg/l

1.4

1.3

0.26

159

(44806071)

279

1.24

0.80

1.1

—

(40758358) Immune stain study

107

0.62

0.77

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

142

758

1.14

0.76

1.6

1.7

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.93

0.76

1.6

2.1

—

(3042733) HLA Ab [Presence] in Serum

122

848

0.87

0.75

4.6

5.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

668

3833

1.06

0.74

1.1

u/ml

1.5

0.03

235

1451

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

222

1222

1.10

0.72

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

223

1.25

0.72

1.1

2.1

—

(3051101) Glucose [Moles/volume] in Cord blood

453

0.83

0.72

4.6

5.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

175

1.28

0.70

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

1109

7020

0.96

0.70

2.4

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

143

1.32

0.70

1.1

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.70

0.69

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

219

1.25

0.69

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

133

1.32

0.68

1.1

1.0

u/ml

0.2

0.07

(40763480) Human metapneumovirus Ag [Presence] in Specimen

102

1.37

0.67

1.1

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

253

1.22

0.67

1.3

1.4

74.4

72.5

0.19

212

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.64

0.65

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

129

1.32

0.65

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.79

0.65

1.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.79

0.65

1.2

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

111

593

1.14

0.63

1.1

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.45

0.63

1.0

1.2

—

(3013762) Body weight Measured

0.65

0.63

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

0.69

0.61

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

794

5041

0.96

0.61

4.3

3.1

mg/l

25.2

27.8

1.23

492

3230

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

389

2214

1.07

0.61

3.3

3.8

u/ml

33.5

57.8

3.93

381

2192

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

147

1.28

0.60

3.1

3.2

pmol/l

97.4

57.5

0.17

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.82

0.60

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

410

2648

0.94

0.60

1.0

1.1

u/ml

4.1

4.0

0.05

151

1037

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.43

0.59

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

188

1250

0.91

0.58

1.1

1.0

u/ml

0.6

1.5

1.17

271

(3021162) Amylase [Enzymatic activity/volume] in Specimen

364

1.17

0.58

2.8

u/l

1199.8

1764.4

0.28

324

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

170

1.25

0.57

1.2

mg/l

42.2

48.8

0.94

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.38

0.57

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.63

0.56

1.5

1.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.34

0.56

1.0

u/ml

0.2

0.5

0.56

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.35

0.55

1.2

1.1

u/field

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

133

0.73

0.55

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

161

889

1.10

0.54

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

1.32

0.54

1.3

1.4

u/field

1.4

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.58

0.54

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

199

1.22

0.54

1.1

—

(3034426) Prothrombin time (PT)

136

745

1.11

0.54

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.49

0.54

1.1

—

(3034614) HLA Ag [Interpretation]

1.52

0.53

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

139

0.74

0.53

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

341

1.16

0.51

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

331

0.84

0.50

1.9

1.8

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.57

0.50

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.57

0.50

1.7

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

1.48

0.49

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

280

1.17

0.49

1.0

—

(3003577) Lead [Moles/volume] in Blood

174

1.22

0.49

1.4

umol/l

0.3

0.2

0.28

(3001556) Androgen free Index in Serum or Plasma

141

1.25

0.49

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

103

561

1.12

0.47

1.5

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.58

0.47

1.2

3.5

—

(3033799) Differential panel - Peritoneal fluid

132

730

1.10

0.46

2.0

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

570

3314

1.04

0.46

4.4

5.2

umol/l

343.5

370.3

4.37

491

2860

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

265

1.17

0.46

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

237

1.18

0.46

1.2

1.1

u/l

23.0

19.9

0.31

156

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.31

0.46

1.2

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

1.36

0.45

1.7

1.6

—

(3025315) Body weight

204

1.19

0.45

4.2

4.4

—

(40759632) Porphyrins [Mass/mass] in Stool

1.69

0.44

1.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

249

1417

1.07

0.44

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.47

0.44

1.4

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.47

0.44

1.1

1.2

nmol/24h

79.1

97.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.43

0.43

2.6

1.4

mmol/24h

2.2

2.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

167

0.80

0.42

2.1

11.3

17.2

0.42

(3010726) Horse dander IgE Ab [Units/volume] in Serum

507

3211

0.96

0.41

1.1

u/ml

2.1

1.8

0.14

112

738

(3023511) Choriogonadotropin [Units/volume] in Urine

396

2522

0.95

0.41

1.4

1.3

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

567

3310

1.04

0.40

1.1

u/ml

1.0

1.1

0.19

211

1316

(46235168) Fasting glucose [Moles/volume] in Blood

284

0.86

0.40

1.3

2.1

mmol/l

6.8

7.3

0.44

118

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

359

2290

0.95

0.40

1.0

u/ml

0.2

0.6

1.52

468

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

132

0.78

0.40

3.2

3.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

361

1.13

0.39

1.3

ng/l

119.3

107.4

0.08

243

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

322

0.87

0.39

2.4

2.7

pmol/l

51.8

70.6

1.05

277

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.72

0.39

1.0

3.3

35.2

20.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

131

733

1.09

0.38

1.8

e6/l

15985.3

11322.0

0.39

393

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.68

0.38

1.5

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.68

0.38

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

203

1.17

0.37

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

146

823

1.08

0.36

2.0

1.9

e6/l

10751.5

2423.5

0.69

556

(3026250) Tacrolimus [Mass/volume] in Blood

165

1073

0.93

0.36

35.7

35.1

ug/l

7.4

7.3

0.05

146

972

(3036312) Salmon IgE Ab [Units/volume] in Serum

103

1.24

0.35

1.0

1.1

u/ml

0.0

0.8

1.41

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1247

7749

0.98

0.34

1.7

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

509

2979

1.04

0.34

1.8

2.3

titre

2.1

9.1

2.33

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.32

0.33

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

535

1.09

0.33

1.1

u/ml

15.8

10.5

0.28

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1187

7373

0.98

0.33

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

104

582

1.09

0.32

1.2

1.3

g/l

12.3

13.5

0.69

453

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

325

1888

1.05

0.32

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

129

841

0.93

0.32

1.5

1.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.71

0.32

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.34

0.31

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

107

0.79

0.30

1.1

—

(40758292) HTLV I+II Ab panel - Serum

364

1.10

0.29

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

106

1.20

0.29

1.0

u/ml

0.2

1.8

0.77

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

178

0.85

0.29

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

123

1.18

0.28

1.6

1.5

mmol/l

24.0

23.0

0.51

(3014133) Dog dander IgE Ab [Units/volume] in Serum

445

2795

0.97

0.28

1.1

u/ml

4.3

3.7

0.29

167

1046

(3022475) Manganese [Moles/volume] in Blood

145

0.84

0.28

1.1

1.3

—

(3016879) Cocaine [Presence] in Urine

1049

6506

0.98

0.27

2.5

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

366

2302

0.97

0.26

2.3

2.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.21

0.26

1.4

1.3

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.21

0.26

1.0

u/ml

0.1

0.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

222

1.12

0.25

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

169

0.86

0.25

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

292

1.10

0.25

1.2

1.3

20.2

25.1

0.49

230

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

263

1.11

0.25

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.70

0.24

1.2

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

275

1.10

0.24

14.0

8.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.23

0.24

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.29

0.23

5.7

5.5

mmol/l

0.4

0.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

350

2196

0.97

0.23

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.21

0.23

1.0

u/ml

0.2

0.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

376

1.08

0.22

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

475

2963

0.97

0.22

1.4

nmol/l

0.3

0.4

1.81

326

2258

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.18

0.22

1.2

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.21

0.22

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.21

0.22

1.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

213

1242

1.04

0.21

1.1

1.0

u/ml

0.4

3.2

0.94

311

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

211

0.89

0.21

2.1

60.9

59.5

0.06

132

(3013945) Hepatitis B virus e Ab [Presence] in Serum

134

0.86

0.21

1.5

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

378

1.08

0.20

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

378

1.08

0.20

1.1

1.2

—

(44806420)

103

662

0.94

0.20

2.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.21

0.20

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

308

1.08

0.20

1.0

ug/l

80.8

82.3

0.09

249

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

555

0.94

0.19

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.24

0.19

9.7

8.5

46.0

46.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

909

5426

1.02

0.19

2.0

2.1

u/l

3095.9

5019.7

1.74

309

2094

(3011325) HIV 1+2 Ab [Presence] in Serum

111

1.15

0.19

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

268

1.09

0.19

1.1

u/ml

0.5

0.3

0.14

165

(4038314)

107

0.85

0.19

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

471

0.94

0.17

3.0

ng/l

68.4

108.6

1.16

199

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.72

0.17

1.2

4.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

147

1.12

0.17

1.0

u/ml

0.1

0.7

1.34

114

(3017509) Phencyclidine [Presence] in Urine

220

0.91

0.17

1.3

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

153

1.11

0.16

1.0

u/ml

0.0

1.9

0.77

116

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

821

5065

0.98

0.16

1.4

pmol/l

144.4

141.9

0.04

799

4944

(3027974) Hepatitis B virus e Ag [Presence] in Serum

137

0.89

0.16

1.5

1.4

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.14

0.15

1.1

1.4

umol/l

—

1770.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

166

1.10

0.15

1.0

u/ml

0.0

0.2

1.09

107

(40763590) HLA-DQ beta [Type]

1.14

0.14

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

274

1.06

0.12

5.7

7.7

umol/l

0.4

0.05

249

(3009677) Dengue virus Ab [Presence] in Serum

1.14

0.12

1.1

—

(40760410) HLA-B [Type] by High resolution

1.13

0.12

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.13

0.12

1.0

—

(40760409) HLA-A [Type] by High resolution

1.13

0.12

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.12

0.11

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

111

651

1.04

0.11

1.1

1.2

—

(3035060) Mercury [Moles/volume] in Blood

1.17

0.10

2.0

1.6

nmol/l

15.3

9.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.14

0.09

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

207

0.94

0.09

3.3

2.2

mmol/l

0.7

1.2

0.82

143

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

230

1370

1.02

0.09

1.1

—

(3013862) HLA-DP [Type]

1.10

0.08

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

607

0.97

0.08

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.88

0.08

1.2

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

135

838

0.98

0.07

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.87

0.07

1.4

2.6

nmol/l

6.0

29.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.84

0.07

11.3

9.1

—

(40768800) Prostate Pathology biopsy report

807

4866

1.01

0.06

1.2

—

(3044007) Cell count panel - Peritoneal fluid

107

664

0.98

0.06

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.92

0.05

1.2

1.1

nmol/l

304.9

258.6

0.32

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

608

0.98

0.05

1.1

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

160

0.95

0.05

1.0

u/ml

0.0

2.4

0.61

(4035726)

3459

21057

1.00

0.05

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

174

1.05

0.05

2.5

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

131

808

0.98

0.04

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

109

1.06

0.04

1.1

36.0

35.8

0.08

100

(40768446) Kidney Pathology biopsy report

155

953

0.99

0.04

1.5

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

195

0.97

0.03

1.3

ml/s/173m2

0.9

1.6

0.97

125

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

158

0.96

0.03

1.0

u/ml

0.0

0.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

406

1.02

0.02

1.6

1.8

ug/l

2.2

2.9

0.39

251

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

105

1.04

0.01

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.95

0.01

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

978

5933

1.00

0.00

1.3

miu/ml

201.3

223.7

1.11

385

2623

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

147

0.99

0.00

1.0

u/ml

0.3

0.7

0.47

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

116

702

1.00

0.00

1.1

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

308

1871

1.00

0.00

1.4

1.3

pmol/l

76.5

123.1

0.52

125

587

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

289

1752

1.00

0.00

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

267

1.00

0.00

1.1

u/ml

0.6

3.8

0.83

196

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.97

0.00

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

132

801

1.00

0.00

1.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

0.98

0.00

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

118

0.98

0.00

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.8

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.3

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

7.6

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.89

0.00

2.0

2.2

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLOPATHY and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLOPATHY	1.088 [1.01, 1.18]	0.033
Birth year	0.995 [0.99, 1.0]	0.211

During the follow-up period (1.1.1998 — 31.12.2019), 26563 out of 141151 females with M13_SPONDYLOPATHY died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLOPATHY	1.173 [1.08, 1.28]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 26315 out of 119872 males with M13_SPONDYLOPATHY died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLOPATHY.

N-year risk	Females	Males
1	0.088%	0.208%
5	0.528%	1.417%
10	1.408%	3.544%
15	2.861%	6.609%
20	5.11%	11.056%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLOPATHY – Spondylopathies

GWS hits: 52

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spondylopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints